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Abstract 
Molecular evolution is a key strategy in the development of novel diagnostics and 
therapeutics. Libraries of mutant variants are generated and those with desired properties 
selected after screening. However, large scale screening is expensive and time-consuming and 
has become a bottleneck. The fluorescent properties of the green fluorescent protein (GFP) 
are used in quantitative and qualitative screening. An attractive approach is to take advantage 
of the fact that a correlation exists between the solubility of an upstream fusion partner to 
GFP and observed fluorescence when the fusion protein is expressed in Escherichia coli (E. 
coli). 
The T-cell receptor (TCR) is a molecule with therapeutic and diagnostic potential. However, 
the single chain TCR (scTCR) shows toxic and aggregation-prone characteristics that may be 
alleviated by molecular evolution. When expressed in E. coli, scTCR and antibody (Ab) based 
molecules such as single chain fragment variable (scFv), need the oxidizing environment of 
the periplasm to form disulfide bonds and obtain a functional fold. The two scFvs, with 
specificity for two haptens phOx and NIP, are expressed in the periplasm at high and 
moderate levels, respectively. In this study, the scTCR as well as the  NIP and phOx binders 
were genetically fused to GFP and three different mechanisms for translocation from the 
cytosol to the periplasm were compared. The results show that the two scFv fusions with pelB 
leader were transported to the periplasm, but cleaved in the linker region. The same result was 
obtained for anti-phOx-GFP with TorA leader. Neither over-expression of the chaperones 
GroEL-GroES nor FkpA, expression in host strains compensating for codon bias or lacking 
proteases, expression without induction of fusion proteins nor reducing the expression 
temperature to 16°C resulted in expression of full length fusion protein in the periplasm. The 
scTCR-GFP fusion was not transported to the periplasm with the use of neither pelB, DsbA 
nor TorA leader. Neither over-expression of the chaperones GroEL-GroES or FkpA, nor 
expression in a host strain compensating for codon bias resulted in periplasmic yield of fusion 
protein.  
In conclusion, the expression profiles of the scFvs were not preserved when expressed as 
fusions to GFP. The scTCR-GFP fusions were not transported to the periplasm, regardless of 
leader sequence. Further optimization of expression system or construct design is needed to 
obtain a screening platform linking functional fold to observed fluorescence. 
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1 Introduction 
1.1 Recombinant protein expression 
1.1.1 General aspects 
Recombinant protein expression is a necessity for production of proteins for research, 
diagnostics and therapeutics. The main goals of most recombinant protein expressions are to 
be fast, inexpensive, easy to purify and preferably produced in the milligram per liter range 
(Graslund, Nordlund et al. 2008). Many diverse strategies have been tested for tens of 
thousands of different proteins from a variety of classes, and there seems to be no expression 
strategy suitable for all proteins (Graslund, Nordlund et al. 2008). Therefore, the expression 
strategy for each individual protein has to be carefully chosen based on the properties and the 
downstream applications of the protein. In addition, the strategy might have to be optimized 
in order to obtain a product or maximize the functional yield where that is a goal. 
 
When choosing an expression host for recombinant protein production, Escherichia coli (E. 
coli) usually stands out as the first choice because it is cheap and easy to grow, has an 
extensively studied genome, can be grown to high densities and has a very short generation 
time (Terpe 2006). It is therefore possible to test and optimize a variety of strategies in E. coli 
fast and inexpensively. E. coli has been successfully used for expression of recombinant 
proteins from a variety of classes and diverse species, ranging from prokaryotes to humans 
(Graslund, Nordlund et al. 2008). Generally, heterologous proteins are well suited for E. coli 
expression if they are expressed intracellularly and are soluble in their native context. 
However, expression of heterologous proteins in E. coli becomes more challenging when they 
are normally expressed extracellularly, contain disulfide bonds, are glycosylated or form 
hetero-multimers (Baneyx and Mujacic 2004). Expression of eukaryotic proteins with 
posttranslational modifications such as N-glycosylation, has proven difficult as E. coli has not 
been showen to perform this task naturally. However, recent identification of prokaryotic N-
glycosylation systems and the transfer of these to E. coli are opening up the new field of 
glycoengineering with expression of recombinant glycoproteins (Langdon, Cuccui et al. 
2009). Another important feature to consider when expressing recombinant proteins in E. coli 
is the reducing cytoplasm in contrast to the oxidizing periplasm that facilitates disulfide bond 
formation. Hence, expression of recombinant proteins that require disulfide bonds to obtain a 
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functional fold is either targeted to the periplasm by one of the secretory routes or expressed 
in a thioredoxin reductase (trxB) mutant E. coli strain that facilitates disulfide bond formation 
in the cytoplasm (Baneyx and Mujacic 2004; de Marco 2009). Furthermore, a large number of 
mutant E. coli strains are optimized for recombinant protein expression and are commercially 
available as shown in Table 1 (Terpe 2006).  
 
Table 1: Commercially available E. coli strains used for heterologous protein expression and their key features. The table is 
adapted from (Terpe 2006). 
 
 
1.1.2 High throughput screening 
In development of new diagnostics and therapeutics, of the major bottlenecks in the 
identification of new or improved molecules is the single clone screening of pre-selected 
candidates. The need for efficient high quantity and quality screening forms the basis for high 
throughput screening as field and during the past 15 years, great improvements yielding 
increased performance have been achieved. One of the first issues that were addressed was to 
increase the screening capacity by using robotics and thereby automating large parts of the 
screening process. This makes the screening less laborious and much faster than manual 
screening. There has also been a simultaneous down-scaling in sample size to make the 
automation more resource effective. The use of microtiter plates reflects this development as 
many groups have gone from using 96 wells plates to the 384 and 1536 wells plate formats. 
There are examples of groups using 3456 wells microtiter plates (Brandish PE 2006), but the 
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small reaction volume (1-2 µl) and logistics makes them more challenging to use. Therefore, 
more recently there has been a turn in focus towards improving the quality of high throughput 
screening by optimizing more robust assays, reducing the false positives and false negatives 
fractions, improving other statistical parameters such as the Z’-factor (Zahng JH 1999) and 
increasing the sensitivity. According to Mayr and Bojanic (Mayr 2009) the three key factors 
influencing a successful high throughput screening is time, cost and quality. All three factors 
are connected and must be considered according to each other for each screening to achieve 
an optimal output balanced between quantity and quality. 
 
Traditionally, high-throughput screening has been employed in classical drug discovery (e.g. 
combinatorial chemistry). However, the rise of functional proteomics has re-focused both 
academia and the industry through the last decade by embracing the next generation 
biotechnological solutions based on recombinant proteins. The challenge of tomorrow is then 
to accommodate next generation therapeutic and diagnostic scaffolds (Wu, Adams et al. 2008) 
to suitable screening platforms, preferably preserving the high throughput features. 
 
A schaffold which has been extensively studied is the monoclonal antibody (mAb) and it has 
already resulted in approved therapeutics (Carter 2006). The mAb can be engineered to bind 
to almost anything, but there are still classes of ligands that are not effectively targeted by 
mAbs. One such class of ligands is the peptide/major histocompatibility complex (pMHC) 
which represents a key element in adaptive immunity. The natural receptor of the pMHC is 
the T-cell receptor (TCR) and it represents a molecule with great therapeutic potential 
(Molloy, Sewell et al. 2005). However, TCRs have proven difficult to express soluble due to 
the toxic and aggregation prone characteristics. Therefore, a screening platform is necessary 
for identification of TCR clones with improved characteristics. 
 
1.1.3 Protein folding 
Folding of recombinant proteins is a crucial step to obtain soluble and functional protein. In 
the cytoplasm of E. coli, a polypeptide can receive folding assistance from several molecular 
chaperones as seen in Figure 1. The general mechanism of molecular chaperones is to bind to 
nonpolar segments of polypeptides to shield the proteins from aggregating and stabilize 
intermediate folding conformations (Baneyx and Mujacic 2004). Trigger factor (TF) or 
DnaK-DnaJ are the first chaperones to bind the nascent polypeptide in need of folding 
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assistance as it emerges from the ribosome (Deuerling, Patzelt et al. 2003). After the release 
from TF or DnaK-DnaJ, the polypeptide can fold into its native conformation or halt at an 
intermediate state. In the latter case, the polypeptide can cycle between DnaK-DnaJ bound 
and unbound state, reaching new intermediates and finally the native conformation or receive 
aid from GroEL-GroES (Ewalt, Hendrick et al. 1997). The folding chaperones GroEL-GroES 
consist of a large chamber where the polypeptide is shielded from the environment and can 
reach intermediate conformations without aggregating (Hartl and Hayer-Hartl 2002). The cell 
is also equipped with holding chaperones (e. g. IbpA/B, Hsp31, Hsp33) that keep 
polypeptides unfolded and prevent aggregation until they can bind a folding chaperone. If 
aggregates are formed, they can be solubilized by disaggregation chaperones (e. g. ClpB) 
(Baneyx and Mujacic 2004). The chaperone level is often upregulated as a result of stress in 
the cell to prevent misfolding and promote refolding of proteins (Baneyx and Mujacic 2004). 
Overexpression of recombinant proteins in need of folding assistance induces stress on the 
cell and the folding machinery easily becomes overloaded, often resulting in inclusion body 
formation and proteolytic degradation. A well documented strategy to increase the folding 
capacity of the cell and overcome these problems is to over-express TF, DanK-DnaJ or 
GroEL-GroES, either alone or in combination (Nishihara, Kanemori et al. 2000; Baneyx and 
Palumbo 2003). 
 
Also the periplasmic space contains chaperones which aid proteins reach their native fold, as 
seen in Figure 2. The main substrates of the folding chaperone Skp are outer membrane 
proteins which are assisted in the folding and membrane insertion processes (Chen and 
Henning 1996; Schafer, Beck et al. 1999; Walton and Sousa 2004). FkpA is a peptidylprolyl 
cis/trans isomerase (PPIase) which also acts as a periplasmic folding chaperone with broad 
substrate specificity (Missiakas, Betton et al. 1996; Arie, Sassoon et al. 2001). Previous 
studies have shown increased soluble periplasmic yields of secreted recombinant proteins 
when overexpressing Skp (Bothmann and Pluckthun 1998) or FkpA (Bothmann and 
Pluckthun 2000; Arie, Sassoon et al. 2001; Gunnarsen, Lunde et al. submitted). In addition to 
these two generic chaperones, the periplasm contains specialized chaperones (e.g. SurA, 
LolA, PapD, FimC), PPIases (e. g. SurA, PpiD, PpiA) and proteins involved in disulfide bond 
formation (e. g. the Dsb-family) (Baneyx and Mujacic 2004). 
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Figure 1: Schematic overview of cytoplasmic chaperones. Conventional folding routes for nascent polypeptides are indicated 
by black arrows. Unfolding and aggregation of thermolabile proteins induced by stress is indicated by red arrows. The green 
arrows indicate alternative routes for recombinant proteins that fail in the classical folding pathway. This figure is adapted 
from (Baneyx and Mujacic 2004).  
 
1.1.4 Secretory pathways 
Many proteins serve their function outside the cytoplasm and need to be inserted into a 
membrane, transported to the periplasm or secreted to the extracellular space. The main routes 
of transport to the periplasm are the general secretion pathway (Sec-pathway) (Driessen, 
Manting et al. 2001) and the twin arginine transporter pathway (Tat-pathway) (Berks, Palmer 
et al. 2005). In addition, there are more specialized pathways such as the YidC dependent 
pathway which is dedicated to insertion and folding of membrane proteins (Kol, Nouwen et 
al. 2008) and the type I-V protein secretion systems which mainly function in the 
translocation and secretion of proteins across the outer membrane in gram-negative bacteria 
such as E. coli (Henderson, Navarro-Garcia et al. 2004; Christie, Atmakuri et al. 2005; 
Backert and Meyer 2006; Cornelis 2006; Johnson, Abendroth et al. 2006). The main focus 
here will be on translocation of proteins to the periplasm, hence the YidC dependent pathway 
and the type I-V protein secretion systems will not be discussed further. 
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Proteins targeted for translocation to the periplasm contain an N-terminal signal sequence, 
also named leader peptide. Proteins containing such a signal sequence are preproteins and 
become a mature protein upon leader peptide cleavage by a signal peptidase after 
translocation (Dev and Ray 1990; Economou 1999). Signal sequences seem to have some 
general features and contain a positively charged n-region, a central hydrophobic h-region, 
and a c-region which is more polar than the h-region (von Heijne 1985), but still there is great 
variety in the known functional signal sequences. However, predictions of protein transport 
can be performed using bioinformatics tools, e.g. SignalP, TatP or SecretomeP (Center for 
biological sequence analysis, Technical university of Denmark), PSORTb (Brinkman 
Laboratory, Simon Fraser University) or PPSearch (European Bioinformatics Institute), based 
on computational algorithms such as artificial neural networks and hidden Markov models 
(Gardy, Laird et al. 2005; Emanuelsson, Brunak et al. 2007). 
 
 
Figure 2: Overview of secretory pathways and periplasmic folding. (a) indicates the SRP-dependent Sec-pathway. (b) 
indicates the SecB/conventional Sec-pathway. (c) indicates the Tat-pathway. Folding pathways, degradation and aggregation 
are indicated in the periplasm. This figure is adapted from (Baneyx and Mujacic 2004). 
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The Sec-pathway 
The Sec-pathway translocates unfolded polypeptides to the periplasm by two main targeting 
routes; the co-translational signal recognition particle (SRP)-dependent route or the post-
translational SecB-dependent route (Driessen, Manting et al. 2001). Both routes utilizes the 
protein conducting channel (PCC) consisting of the heterotrimeric integral membrane protein 
complex SecYEG, and the peripheral associated ATPase SecA, a molecular motor which 
drives the translocation of the targeted proteins (de Keyzer, van der Does et al. 2003). SecA 
has been shown to bind both the signal sequence and mature regions of the preprotein 
(Papanikou, Karamanou et al. 2005). In the co-translational SRP-dependent pathway, the 
GTP-driven elongation of the polypeptide chain by the ribosome seems to be the main 
translocation force while translocation in the SecB-dependent pathway is powered by cycles 
of ATP hydrolysis and conformational changes of SecA (Natale, Bruser et al. 2008). 
 
For the post-translational route, the emerging polypeptide is bound by TF as it emerges from 
the ribosome during synthesis (Buskiewicz, Deuerling et al. 2004). When the chain is released 
from the ribosome, it is bound by SecB which keeps the peptide unfolded and targets it to the 
Sec machinery (Driessen 2001). SecB then transfers the unfolded polypeptide chain to SecA 
(Driessen 2001). The polypeptide is threaded through the channel formed by SecYEG driven 
by energy from the proton motive force captured by SecDFYajC. In the translocation process 
the signal sequence is cleaved off by signal peptidases. Many different signal sequences have 
been used for periplasmic heterologous expression, e. g. OmpA, PelB and PhoA (Thie, 
Schirrmann et al. 2008). 
 
The SRP-dependent pathway translocates co-translationally and is involved in both protein 
transport to the periplasm and insertion of proteins in the inner membrane. The SRP binds to 
the N-terminal signal sequence of the polypeptide as it emerges from the ribosome (Luirink, 
von Heijne et al. 2005). The ribosome/emerging-polypeptide/SRP complex then associates 
with the membrane-bound receptor FtsY. By GTP hydrolysis, the ribosome with the nascent 
peptide chain is transferred to SecYEG where the polypeptide chain is translocated to the 
periplasm (Driessen, Manting et al. 2001). Different leader sequences have been used for 
periplasmic heterologous expression, e. g. DsbA, TolB and TorT (Thie, Schirrmann et al. 
2008). 
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Tat-pathway 
The twin arginine translocator (Tat) differs from the SecB- and SRP- dependent pathways as 
it mainly translocates folded or partially folded proteins (DeLisa, Samuelson et al. 2002; 
Robinson and Bolhuis 2004). This translocation mechanism is thought to be important for the 
translocation of proteins that bind cofactors or fold fast and efficiently in the cytoplasm 
(Berks 1996; Berks, Palmer et al. 2005). The Tat-pathway was named because of the twin 
arginine motif found in signal peptides directing translocation through this transporter (Berks 
1996). This twin arginine motif is highly conserved even though studies have revealed 
translocation despite substitution of one arginine with lysine (Hinsley, Stanley et al. 2001). 
Prior to translocation, the polypeptide is expected to fold and assemble with cofactors, if 
required. Polypeptide folding is aided by the folding chaperones previously described and in 
some cases it is also believed to be a quality control to prevent translocation of precursor 
protein, e. g. by the binding of a protein to the signal sequence to shield it from premature 
interactions with the translocation machinery (Pommier, Mejean et al. 1998; Jack, Buchanan 
et al. 2004). Although the translocation mechanism of the Tat-pathway is not fully 
understood,  TatA, TatB and TatC have been identified as the essential translocation 
components (Bolhuis, Mathers et al. 2001). The primary signal sequence recognition occurs 
with TatC (Alami, Luke et al. 2003) and is followed by translocation of the Tat-substrate 
through a channel formed in the membrane with energy provided by the proton motive force 
(Natale, Bruser et al. 2008). 
 
The Tat signal peptides are usually between 25 and 50 amino acids (aa) and are therefore on 
average longer than the signal peptides directing translocation through the Sec-pathway 
(Bruser 2007). A wide variety of recombinant proteins have been successfully targeted to 
periplasm via the Tat-transporter using the TorA signal sequence (DeLisa, Samuelson et al. 
2002; Blaudeck, Kreutzenbeck et al. 2003; DeLisa, Tullman et al. 2003; Thammawong, 
Kasinrerk et al. 2006). 
 
1.1.5 Quality control/proteolysis 
Proteins unable to reach their native conformation are degraded by proteases to prevent 
accumulation of potentially deleterious peptides and to recycle aa residues. The proteases 
Lon, ClpYQ/HslUV, ClpAP, ClpXP and FtsH unfolds and degrades substrate polypeptide 
chains with the aid of peptidases in the cytoplasm of E. coli (Baneyx and Mujacic 2004). The 
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periplasm also contains proteases that impede aggregate formation. The primary periplasmic 
protease is considered to be DegP and is supplemented by the additional proteases DegS, 
DegQ, Protease III and OmpT (Baneyx and Mujacic 2004). 
 
1.2 The T-cell receptor 
The interaction between T cells and specialized antigen presenting cells (APCs) is one of the 
key interactions in both thymic selection and development of adaptive immunity. The 
specificity of this interaction is provided by the TCR on the T cell membrane and the pMHC 
on the surface of APCs. Production of soluble MHC tetramers has made it possible to track 
the course of an immune response in a specific manner. The counter approach, namely to 
specifically track specific antigen persentatino on  an APC still remains elusive mainly due to 
technical challenges in soluble TCR expression. In addition, soluble TCRs have a great 
potential as therapeutics and diagnostics (Molloy, Sewell et al. 2005). 
 
TCR is a glycosylated heterodimer comprised of an α- and a β-chain or a γ- and a δ-chain. 
Only a small subset of TCRs is composed of γ- and δ-chains. The main focus in this study 
will be on the αβ TCR. Each chain is comprised of two extracellular domains, namely a 
variable domain and a constant domain, in addition to a transmembrane segment. These 
domains contain inter-domain disulfide bonds that are important to obtain a functional fold. In 
addition, the two chains are covalently connected by a membrane proximal disulfide bond. A 
schematic view of the αβ TCR is shown in Figure 3. 
 
The TCR interacts with the pMHC through the variable domains. Therefore, expression of 
soluble TCRs has been performed by genetically connecting the variable domains by a linker 
(Maynard, Adams et al. 2005; Gunnarsen, Lunde et al. submitted). This creates a single chain 
TCR (scTCR) molecule that is translated as one polypeptide that retains the pMHC 
specificity. The immunoglobulin (Ig) fold of the TCR variable domains shows a strong 
structural resemblance to the variable domains of antibodies (Abs) (Halaby, Poupon et al. 
1999). Therefore, expression of the Ab based single chain fragment variable (scFv) molecules 
and scTCRs face many of the same challenges. Targeting expression of scFvs to the 
periplasm of E. coli facilitates disulfide bond formation and is a very successful strategy. 
However, functional expression of scTCRs is dependent of ectopic folding assistance to 
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obtain soluble periplasmic protein (Wulfing and Pluckthun 1994; Maynard, Adams et al. 
2005; Gunnarsen, Lunde et al. submitted). 
 
 
Figure 3: A schematic view of the αβ TCR structure. The TCR is a heterodimer composed of two glycosylated chains, the α- 
and β-chains. Each chain is composed of a variable domain, constant domain and a transmembreane segment. The two chains 
are covalently connected by a membrane proximal disulfide bond. The figure is adapted from Immunobiology 7th edition 
(Murphy, Travers et al. 2008).  
 
 
The scTCR characteristic of the T-cell clone 4B2A1 from the murine MOPC315 myeloma 
model has been chosen to serve as a fusion partner to the green fluorescent protein (GFP). 
This TCR has been displayed on phage and expressed as a soluble entity, but as most TCRs it 
is toxic to the bacterial host cell and aggregation-prone. However, molecular evolution of the 
TCR is expected to improve functional expression. 
 
1.3 GFP as a folding reporter 
1.3.1 GFP 
The green fluorescent protein (GFP) was first cloned from the jellyfish Aequorea victoria in 
1992 (Prasher, Eckenrode et al. 1992). Since then, GFP has been subject to extensive 
mutagenesis and new clones have been identified with altered characteristics, in addition to 
the cloning and characterization of fluorescent proteins from several other species (reviewed 
in (Zimmer 2002; Shaner, Patterson et al. 2007)). The three-dimensional structure of GFP and 
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its derivatives is a beta-barrel consisting of 11 anti-parallel strands and a coaxial helix as 
shown in Figure 4 (Ormo, Cubitt et al. 1996). The fluorescence is due to the formation of an 
optically active chromophore with the key aas Ser65-Tyr66-Gly67 (wild type), which gives 
the major excitation and emission peaks at 395nm and 509nm, respectively. The isolation of a 
fluorescence-activated cell sorting (FACS) -optimized mutant, GFPmut2, with S65A, V68L 
and S72A substitutions gave a GFP with a red-shifted excitation maximum at 488nm, 
improved folding characteristics and increased solubility in E. coli (Cormack, Valdivia et al. 
1996). Simultaneously, the “enhanced” GFP, cycle 3, was isolated with F99S, M153T and 
V163A mutations which was shown to reduce aggregation and increase chromophore 
activation when expressed in E. coli (Crameri, Whitehorn et al. 1996). Furthermore, an 
A206K mutation has been shown to reduce GFP’s tendency to dimerize and produces a more 
monomeric GFP (Zacharias, Violin et al. 2002). Of particular interest are the folding reporter 
GFP (Waldo, Standish et al. 1999) and the superfolder GFP (Pedelacq, Cabantous et al. 
2006). The folding reporter GFP was fused C-terminally to 20 proteins that had previously 
been expressed alone with different degrees of solubility. Cells expressing these fusion 
proteins showed a strong correlation between the fluorescence measured and the solubility of 
the upstream fusion partner. In contrast, the superfolder GFP has additional mutations giving 
greater resistance to chemical denaturants and improved folding kinetics. Therefore, this 
superfolder GFP folds well and fluoresce even when it is fused to poorly folded peptides. 
 
Figure 4: The structure and approximate dimensions of Aequorea victoria derivated fluorescent proteins. The figure is 
adapted from (Shaner, Patterson et al. 2007). 
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1.3.2 GFP fusion proteins 
Many proteins are difficult to express in soluble form in E. coli. Different approaches to 
increase functional expression include over-expression of chaperones, altered expression 
conditions, targeting proteins for expression in the periplasm and expression in specialized 
host strains (Baneyx and Mujacic 2004; Graslund, Nordlund et al. 2008). Fusion of proteins to 
more soluble partners have also been shown to increase expression levels (Makrides 1996) 
and even altered the subcellular localization (Zhang, Brokx et al. 2006). However, these 
strategies do not alter the intrinsic sequence dependent folding characteristics of a protein and 
will not work for all. A putative strategy is therefore to fuse the protein of interest to a folding 
reporter protein which gives information on the folding status. 
 
Protein structure is strongly correlated to the biological activity and misfolding of proteins 
can lead to loss of activity, aggregation, proteolysis and even cell death (Baneyx and Mujacic 
2004). The most relevant approach to measure folding quality during protein expression is 
therefore to asses the biological activity. However, such assays often require a laborious 
experimental protocol. Therefore, fusing the protein of interest to GFP is a solution since the 
measured fluorescence have been shown to correlate with the folding ability of the protein 
(Waldo, Standish et al. 1999). This strategy has proven applicable as several studies have 
successfully used GFP as an optical folding reporter (Waldo, Standish et al. 1999; Nakayama 
and Ohara 2003; Wang and Chong 2003; Omoya, Kato et al. 2004). 
 
Several attempts have been made to fuse GFP to scFv (Griep, van Twisk et al. 1999; Casey, 
Coley et al. 2000; Schwalbach, Sibler et al. 2000). The scFv requires intradomain disulfide 
bond formation to obtain a functional fold.  Therefore, attempts were made to target the 
fusion protein for periplasmic expression. However, utilizing the Sec-pathway with a pelB 
leader yields were still low (Griep, van Twisk et al. 1999; Casey, Coley et al. 2000). Further 
approaches such as alternative leader sequences, over-expression of chaperones, expression in 
specialized host stains and altered expression conditions could improve periplasmic 
expression and functionality. 
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2 Aim of the project 
As highlighted in the introduction, there is a need for a high throughput screening system to 
evaluate whether protein variants have obtained a functional fold during molecular evolution. 
When used as a protein-of-interest fusion partner, GFP may serve as an indicator of correct 
folding, since the intensity of fluorescence emitted from host cells producing fusion protein 
correlates with functional folding of the protein-of-interest.  
The study was set up to investigate the feasibility for using GFP as fusion partner for scFv 
and scTCR variants, all of which contain Ig-domains that require the formation of an 
intradomain disulfide bridge to reach a functional fold. Such a bridge may be formed in the 
oxidizing environment of the E.coli periplasmic compartment. One scTCR and two different 
scFvs were chosen because they exhibit three distinct and different periplasmic expression 
profiles in E. coli, ranging from poor to very good.  
 
The aim was separated into two sub-goals: 
 
1. To evaluate the periplasmic expression profile of the three model proteins as fusions to 
GFP. A major issue was to investigate whether the GFP fusions retained the expression 
profiles earlier observed for “naked” scFvs and the scTCR. Three translocation 
mechanisms for periplasmic targeting were evaluated using both the Sec- and Tat-
pathways for transport from cytoplasm to periplasm. 
 
2. To develop the GFP-based Ig-fold tracker such that sufficient quantities of functional 
fusion protein were produced to allow downstream purification and use.  
 
To optimalize periplasmic yields, the effect of several expression parameters were 
investigated, such as i) over-expression of the chaperones GroEL-GroES or FkpA, ii) 
expression in host strains that compensate for codon bias or lacking proteases, iii) 
expression without induction and iv) reducing the expression temperature to 16°C. 
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3 Materials and methods 
3.1 General materials 
3.1.1 Primers and other oligonucleotides 
Synthetic oligonucleotides used for cloining in this study were purchased fromMWG-Biotech 
(Ebersberg, Germany) and are shown in Table 2.  
 
Table 2: Over view of primers and other oligonucleotides used in this study. 
Oligonucleotide Sequence 
TorAB7_EcoRI_new 5’-ATAGAATTCATTAAAGAGGAGAAATTAACCATGAACAATAACGATC 
TCTTTCAGAC-3’ 
TorAB7_1NcoI 5’-GGCCATGGCCGCAGTCGCACGTC-3’ 
TorAB7_2NcoI 5’- GGCCATGGCCGCTTGCGCCGCAGTCGCACGTC-3’ 
DsbA_1_Plus 5’-AATTCATTAAAGAGGAGAAATTAACCATGAAAAAGATTTGGCTGGCG 
CTGGCTGGTTTAGTTTTAGCGTTTAGCGC-3’ 
DsbA_1_Minus 5’-CATGGCGCTAAACGCTAAAACTAAACCAGCCAGCGCCAGCCAAATCT 
TTTCATGGTTAATTTCTCCTCTTTAATG-3’ 
DsbA_2_Plus 5’- AATTCATTAAAGAGGAGAAATTAACCATGAAAAAGATTTGGCTGGC 
GCTGGCTGGTTTAGTTTTAGCGTTTAGCGCATCGGC-3’ 
DsbA_2_Minus 5’-CATGGCCGATGCGCTAAACGCTAAAACTAAACCAGCCAGCGCCAGCC 
AAATCTTTTTCATGGTTAATTTCTCCTCTTTAATG-3’ 
DsbA_3_Plus 5’- AATTCATTAAAGAGGAGAAATTAACCATGAAAAAGATTTGGCTGG 
CG CTGGCTGGTTTAGTTTTAGCGTTTAGCGCATCGGCGGC-3’ 
DsbA_3_Minus 5’-CATGGCCGCCGATGCGCTAAACGCTAAAACTAAACCAGCCAGCGCC 
AGCCAAATCTTTTTCATGGTTAATTTCTCCTCTTTAATG-3’ 
pGB7NotI_fw 5’-ATATGCGGCCGCTGGCAGTAAAGGAGAAGAACTTTTCACTG-3’ 
pGB7BamHI_rev 5’- ATATGGATCCTTTGTATAGTTCATCCATGCCATG -3’ 
a1159g 5’- GGAAAACTACCTGTTCCGTGGCCAACACTTGTCAC-3’ 
g1607a_c1608a_c1609a 5’-AACCATTACCTGTCCACACAATCTAAACTTTCGAAAGATCCCAACGA 
AAAG-3’ 
 
Table 3: Overview of E. coli strains for protein expression. 
 
E. Coli strain 
 
Genotype 
Antibiotics 
resistance 
XL-1 Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 
lac [F’ proAB lacIqZ∆M15 Tn10 (Tetr)] 
Tetr 
XL-1 Blue pGro7 
 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 
lac [F’ proAB lacIqZ∆M15 Tn10 (Tetr)] pGro7 
Camr, Tetr 
RosettaBlueTM(DE3) 
pLysS 
endA1 hsdR17 (rK12– mK12+) supE44 thi-1 recA1 
gyrA96 relA1 lac (DE3) F′[proA+B+ 
lacIqZM15::Tn10] LysSRARE (CamR, TetR)
Camr, Tetr 
BL21 (DE3) F- ompT hsdSB(rB-mB-) gal dcm (DE3)  
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3.1.2 Bacterial strains  
Four different E. coli strains were used in this study and are shown in Table 3. XL-1 Blue was 
obtained in house and used for protein expression and cloning. XL-1 Blue pGro7 and BL21 
(DE3) were obtained in house and used for protein expression. RosettaBlueTM(DE3) pLysS 
(Darmstadt, Germany) was purchased from Novagen and used for protein expression. 
 
3.1.3 Antibodies and other reagents 
Ab and other reagents used in immunodetection were anti-GFP Ab (Abcam), SA-HRP 
(Amersham), anti-His-6-tag (C-term) Ab (Invitrogen), anti-mouse IgG-HRP Ab from sheep 
(Amersham), rabbit anti-GroEL Ab (Sigma), donkey anti-rabbit IgG Ab(Amersham), anti-
Flag M2-HRP Ab (Sigma), anti-human lambda L-chain Ab (Dako) and donkey anti-rabbit 
IgG HRP Ab (Amersham). 
 
All restriction endonucleases (RE) were purchased from New England Biolabs (NEB) 
(Ipswich, MA, USA). T4 DNA Ligases used in this study were purchased from NEB or 
Roche. The DNA modifying enzyme T4 Polynucleotide Kinase was purchased from NEB 
(Ipswich, MA, USA). Recombinant GFP (rGFP) was purchased from Clontech. 
 
3.1.4 Description of parental plasmids 
The pHOG21 derivatives (PMID: 9005945) harboring either a scFv anti-phOx (PMID: 
1368267), or scFv H3 (unpublished) were kind gifts from Affitech AS (Oslo, Norway). In 
pHOG21 scFv H3, the scFv is found as an N-terminal fusion to yellow fluorescent protein 
(YFP) (Ole H. Brekke, personal communication). The pHOG21 derivative pSG1 harboring a 
scFv anti-NIP has been made in-house and described previously (S. Granum, M.Sc. 2000). 
The scTCR Vαβ 4B2A1 has been described previously (PMID: 17925331). The pFKPDN 
plasmid containing this scTCR has been described previously (Gunnarsen, K.S., et al., In 
press). The pFKPEN is a pHOG-Dummy (PMID: 15914190) derivative containing a fkpA 
expression cassette as described for its phagemid counterpart pFKPDN (PIMD: 17925331). 
The pGALD7 plasmid (Løset, G.Å., unpublished) has been made in-house and contains a 
modified T7 terminator sequence. The pB7G plasmid harboring a GFPmut2 mutant (PMID: 
8707053) and a gain-of-function mutant (B7) of the TorA signal sequence (PMID: 12021272) 
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was a kind gift from Dr. G. Georgiou (Department of Chemical Engineering, Institute for Cell 
and Molecular Biology, University of Texas, USA). 
 
The scFvs anti-phOx and anti-NIP, as well as the scTCR Vαβ 4B2A1, were exchanged with 
the scFv H3 in the YFP-containing pHOG21 vector; thereby creating the plasmids pYFP-
phOx, pYFP-NIP and pYFP-scTCR, respectively. The scFv anti-phOx and scTCR Vαβ 
4B2A1 fused to YFP from these new plasmids were then inserted to the pFKPEN vector, 
thereby creating the pYFPFN-phOx and pYFPFN-scTCR, respectively. The construction of 
the pYFP and pYFPFN vectors described above was conducted by Dr. G.Å. Løset 
(unpublished). 
 
3.2 Cloning methods 
3.2.1 Purification of plasmid DNA 
Purification of plasmid DNA was performed using Wizard® Plus SV Minipreps DNA 
Purification System (Promega) following the Centrifugation Protocol. Plasmid DNA was 
eluted from the spin column using destilled H2O (dH2O). DNA concentrations were estimated 
using NanoDrop ND-1000 Spectrophotometer or by Agarose gel Electrophoresis. 
 
3.2.2 Precipitation of DNA 
Precipitation of DNA was performed with seeDNA (Amersham Biosciences) or Pellet Paint 
Co-Precipitant (Novagen), using the manufacturer’s protocol. 
 
3.2.3 Restriction endonuclease digestion of DNA 
RE digestion of DNA was performed using RE or High Fidelity (HF) RE from NEB. The REs 
were used with the appropriate reaction conditions described by NEB. The RE digestions 
were performed under optimal conditions for 1.5 hours or overnight (ON), depending on the 
subsequent application. 
 
3.2.4 DNA modifying enzymes 
To allow ligation of annealed oligos, 5’-phosphate was added by T4 Polynucleotide Kinase 
(NEB) with reaction conditions and procedure according to the manufacturer’s protocol. 
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3.2.5 Agarose gel electrophoresis 
Separation of DNA fragments was performed by agarose gel electrophoresis. The gels 
contained 0.8-3.0% agarose (Lonza) dissolved in 1xTAE buffer (40 mM Tris-acetate, 1mM 
EDTA) and 1µg/ml ethidium bromide. 1 kb DNA Ladder (NEB) or 100 bp DNA Ladder 
(NEB) was prepared and run in parallel to the samples. Proportionate amounts of 6xSB were 
added to the DNA Ladder and all samples before gel loading. Electrophoresis was carried out 
in 1xTAE buffer at 90V for 40-60 minutes. Visualization of DNA was performed by exposure 
to UV-light using BioDoc-It™ Transiluminator system (UVP). 
 
3.2.6 DNA extraction from agarose gel 
The DNA fragments were visualized on a Dual-Intensity Transilluminator (UVP) using the 
low setting of UV-light. The DNA fragments were cut out from the agarose gel with a clean 
scalpel. Extraction of the DNA fragments from the gel slice was performed using QIAquick 
Gel Extraction Kit (QIAGEN) following the manufacturer’s protocol. DNA fragments were 
eluted from the spin column using dH2O. 
 
3.2.7 Ligation of DNA fragments 
Ligation of DNA fragments was performed using T4 DNA Ligase (NEB or Roche) with 
supplemented buffer. Ligation took place under optimal reaction conditions according to the 
manufacturer’s protocol, with an Insert:Vector ratio of 4:1 and a total reaction volume of 
20µl. The ligation mix was incubated ON at room temperature (RT). 
 
3.2.8 PCR amplification of DNA 
Polymerase chain reaction (PCR) was used for amplification of DNA fragments using primers 
with tails containing RE sites. PCR was set up with Phusion DNA Polymerase 
(FINNZYMES) using optimal reaction conditions according to the protocol with a cycling 
program adjusted to the primers used. Controls for each primer were run in parallel. 
Validation of PCR product was done by agarose gel electrophoresis (Section 3.2.5). PCR 
products were purified using QIAquick PCR purification Kit (QIAGEN). Validation of 
purified PCR product was done by agarose gel electrophoresis (Section 3.2.5). 
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3.2.9 QuikChange Multi Site-Directed Mutagenesis 
Multiple site-directed mutations were introduced using QuikChange® Multi Site-Directed 
Mutagenesis Kit (Stratagen) with optimal reaction conditions and procedure according to the 
protocol. Cycling program was adjusted according to the plasmid length.  Dpn I from NEB 
and Electroporation competent XL-1 Blue cells were used instead of the equivalent materials 
supplied by the manufacturer.  
 
3.2.10 Transformation of E. Coli-strains 
Transformation of electroporation competent XL-1 Blue 
XL-1 Blue cells were used both in cloning and protein production. Electroporation competent 
XL-1 Blue cells were thawed on ice. 39µl cells per transformation were transferred to a new, 
pre-chilled Eppendorf tube and kept on ice. 1 µl ligation mix (Section 3.2.7) or other DNA 
sample was added to the cells and mixed by stirring gently with the pipette tip. The sample 
was transferred to a pre-chilled electroporation cuvette (Molecular Bio Products). A Gene 
Pulser™ electroporator apparatus (BioRad) set on 1.3 kV, 200 Ω and 25 µFD was used to 
pulse the cells. 0.96 ml 2xYT was mixed with the sample in the cuvette and the total volume 
of 1 ml was transferred to a new Eppendorf tube and incubated at 37°C for 1 hour. 
Transformation mix was plated out on agar plates with 100 µg/ml ampicillin. The plates were 
incubated upside-down at 37°C ON.  
 
Transformation of CaCl2 competent RosettaBlueTM(DE3)pLysS 
CaCl2 competent RosettaBlueTM(DE3)pLysS (Novagen) cells were transformed according to 
the manufacturer’s protocol. 
 
Preparation of CaCl2 competent XL-1 Blue pGro7 and BL21 (DE3) 
XL-1 Blue pGro7 were made by transformation of electroporation competent XL-1 Blue 
(Section 3.2.10) with the pGro7 plasmid (Takara). CaCl2 competent XL-1 Blue pGro7 and 
BL21 (DE3) were prepared by Ruby Sathiaruby Sivaganesh according to the ISA standard 
protocol.  
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Transformtaion of CaCl2 competent XL-1 Blue pGro7 and BL21 (DE3) 
CaCl2 competent cells were thawed on ice. 100 µl cells were transferred to a pre-chilled 
Eppendorf tube and incubated on ice for 10 minutes. 5 µl of plasmid prep (undiluted or 102 
diluted) was added to the cells and mixed by gently stirring the pipette tip. Incubation of the 
cells continued on ice for 30 minutes. The cells were heat pulsed at 42°C for 3 minutes 
followed by 2 minutes incubation on ice. 0.9 ml of pre-heated 2xYT medium was added to 
each tube of cells and the tubes were incubated at 37°C for 1 hour. 100 µl of sample was 
plated out on agar plates with appropriate antibiotics for selection. Plates were incubated 
upside-down at 37°C ON. 
 
3.3 Construction of plasmids 
All constructs created in this study were designed as shown by the schematic overview in 
Figure 5 A or B. The new plasmids were named with abbreviations describing the fusion 
proteins they express, following the N- to C-terminal order of the expressed entities, e.g. 
pT2scTCR-GFPFN encode the scTCR fused to GFP with a TorA2 leader sequence and the 
over-expression of FkpA. The expression vectors as shown in Figure 5 C. 
 
3.3.1 Subcloning of pPscTCR-YFP   
The scTCR in the Vαβ conformation in fusion to YFP was moved to an expression vector 
without co-expression of FkpA. The pYFPFN-scTCR Vαβ 4B2A1 and pYFP-phOx were 
digested with NcoI and NotI (Section 3.2.3). The DNA fragments from the digests were 
separated by agarose gel electrophoresis (Section 3.2.5). The scTCR cassette and the digested 
vector were extracted from the agarose gel (Section 3.2.6) and ligated together (Section 
3.2.7). Ligation mix was transformed into Electroporation competent XL-1 Blue cells 
(Section 3.2.10). A random selection of clones were inoculated in 5 ml LB-medium supplied 
with 100mM glucose and 100µg/ml ampicillin and incubated at 37°C, ON with 250rpm in a 
shaking incubator (NBS InnOva 4000 Incubator Shaker or JEIO-TECH SI600R). Plasmids 
were isolated and clones were validated by sequencing performed by the Abi-lab (CEES, 
Department of Biology and Molecular Biosciences, University of Oslo). 
 
29 
 
 
Figure 5: A schematic overview of the expression elements and vectors used. The figure shows the different exspression 
elements in (A) and (B): the Lac promoter (Lac); the leader sequence (Leader) being either the PelB-, TorA1-, TorA2-, 
DsbA1-, DsbA2- or DsbA3-leader; the scFv/scTCR cassette being scFv-anti phOx, scFv-anti NIP or scTCR; the linker (A3) 
consisting of three alanine residues; the GFP (GFP); the c-Myc-tag (c-Myc); the His6-tag (His6); the periplasmatic chaperon 
FkpA (FkpA); the ampicillin resistance marker (Amp). The elements are not scaled according to actual size. (C) shows the 
overview of the two different expression vectors used, exemplified by pPphOx-GFP (without FkpA) and pPphOx-GFPFN 
(with FkpA). 
 
3.3.2 Construction of scTCR-YFP fusion constructs with TorAB7 
leaders 
To create pT1-scTCR-YFP and pT2scTCR-YFP, the two leader versions TorA1 and TorA2  
were created by PCR (Section 3.2.8) with the primer mix of TorAB7_EcoRI_new(frwd)/ 
TorAB7_1NcoI(rev) and TorAB7_EcoRI_new (frwd)/TorAB7_2NcoI(rev), respectively. The 
PCR was run with the following program: 98°C for 30 seconds, 30 repeats of denaturation 
(98°C for 10 seconds), annealing (54°C for 10 seconds) and elongation (72°C for 10 seconds) 
followed by 72°C for 5 minutes before cooling to 4°C. The primers contained tails with EcoRI 
or NcoI RE sites. The purified PCR products and pPscTCR-YFP were RE digested with 
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EcoRI and NcoI at 37°C ON (Section 3.2.3). Ligation, transformation and validation of clones 
were performed as described in Section 3.3.1. 
 
3.3.3  Construction of scTCR-YFP fusion constructs with DsbA 
leader 
To create pD1scTCR-YFP, pD2scTCR-YFP and pD3scTCR-YFP, the three leaders DsbA1, 
DsbA2 and DsbA3 were ordered as plus and minus strand oligonucleotides with overhangs as 
if digested with EcoRI and NcoI REs. Annealing of oligos was performed by mixing 2.5 µg of 
each DNA strand in a 1.5 ml eppendorf tube. The tubes were incubated at 95°C for 1 minute 
and cooled down to 4°C. The annealed oligos were treated with T4 Polynucleotide Kinase 
(NEB) with reaction conditions and procedure according to the manufacturer’s protocol. DNA 
from the reaction mixes were precipitated with seeDNA (Section 3.2.2) and resuspended to a 
concentration of approximately 25ng/µl. Ligation of each leader into EcoRI/NcoI digested 
pPscTCR-YFP, transformation and validation of clones were performed as described in 
Section 3.3.1. 
 
3.3.4 Construction of scTCR-GFP and scFv-GFP fusion constructs 
Construction of pPphOx-GFPmut2 
To make pPphOx-GFPmut2, GFPmut2 was amplified with PCR from pB7G using the primers 
pGB7NotI_fw and pGB7BamHI_rev which contains NotI and BamHI RE sites in the tails, 
respectively. The PCR was run with the following program: 98°C for 30 seconds, 30 repeats 
of denaturation (98°C for 10 seconds), annealing (56°C for 15 seconds) and elongation (72°C 
for 10 seconds) followed by 72°C for 5 minutes before cooling to 4°C. The purified PCR 
products and pYFP-phOx were RE digested by NotI and BamHI at 37°C ON as described in 
Section 3.2.3. Ligation, transformation and validation of clones were performed as described 
in Section 3.3.1. pPphOx-GFPmut2 was successfully validated by sequencing.  
 
QuickChange of GFPmut2 
GFPmut2 contains an NcoI RE site it was desirable to remove. In addition we wanted to 
introduce an A206K substitution in the GFP that has been shown to reduce the degree of 
dimerization of GFP (Zacharias, Violin et al. 2002; Shaner, Steinbach et al. 2005). These 
mutations were introduced by QuickChange Multiple Site-Directed Mutagenesis using the 
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primers a1159g and g1607a_c1608a_c1609a with pPphOx-GFPmut2 as template (Section 
3.2.9). The cycling program used was 95°C for 1 minute, 30 repeats of denaturation (95°C for 
1 minute), annealing (55°C for 1 minute) and elongation (65°C for 9 minutes and 12 seconds) 
followed by cooling to 4°C. Transformation and validation of clones were performed as 
described in Section 3.3.1. A validated clone with the desired mutations and the vector pGAL 
were RE digested with NotI and NheI (Section 3.2.3) in a two-step procedure with DNA 
precipitation (Section 3.2.2) in between in order to change optimal buffer for the REs. The 
modified GFPmut2 and the digested vector fragment were ligated, transformed and clones 
validated as described in Section 3.3.1. A clone with validated sequence from the NotI to the 
SalI RE site was digested with these two enzymes in parallel to the vectors pYFP-phOx, 
pYFP-NIP, pPscTCR-YFP, pT1scTCR-YFP, pT2scTCR-YFP, pD1scTCR-YFP, pD2scTCR-
YFP and pD3scTCR-YFP. The NotI/SalI cassette was ligated into the vectors, transformed 
and validated as described in Section 3.3.1. 
 
3.3.5 Assembly of pT2phOx-GFP 
The pT2scTCR-GFP and pPphOx-GFP were digested with NcoI and NotI as described in 
Section 3.2.3. Ligation of the phOx cassette and the pT2scTCR-GFP digested vector, 
transformation, and validation of clones were performed as described in Section 3.3.1 in order 
to create pT2phOx-GFP. 
 
3.3.6 Assembly of scTCR-GFP and scFv-GFP fusion constructs with 
FkpA 
pPphOx-GFP, pPscTCR-GFP, pT2phOx-GFP, pT2scTCR-GFP and pYFPFN-phOx were 
digested with NheI-HF and ScaI-HF as described in Section 3.2.3. Ligation, transformation, 
and validation of clones were performed as described in Section 3.3.1 in order to create 
pPphOx-GFPFN, pPscTCR-GFPFN, pT2phOx-GFPFN and pT2scTCR-GFPFN. 
 
3.4 Recombinant protein expression 
3.4.1 Plasmids used for protein expression 
Plasmids used in protein expression with the respective host strains are shown in Table 4. 
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3.4.2 Standard growth conditions for scTCR-GFP and scFv-GFP 
expression 
Cells were inoculated from glycerol stock into 5 ml LB-medium in a 50 ml tube 
supplemented with 30µg/ml tetracycline, 100 µg/ml ampicillin and 0.1 M Glucose (LBTAG-
medium) for XL-1 Blue. LBTAG-medium supplemented with 20µg/ml chloramphenicol 
(LBTACG-medium) was used for Rosetta Blue (DE3) pLysS and XL-1 Blue pGro7. A LBAG-
medium containing 5 ml LB-medium supplemented with 100µg/ml ampicillin and 0.1 M 
glucose was used for BL21 (DE3). Cultures were incubated at 37°C ON with 250 rpm. The 
ON cultures were reinoculated into 5 ml of appropriate medium in 50 ml tubes with an 
OD600nm~0.1. The cultures were incubated 37°C with 250 rpm until an OD600nm of 0.6-0.8 was 
reached. The cultures were centrifuged 4500g for 10 minutes and resuspended in 5 ml of 
respective medium without glucose and supplemented with 0.1 mM isopropyl-β-D-thio-
galactopyranoside (IPTG) in 50 ml tubes. XL-1 Blue pGro7was in addition supplemented 
with 0.5 mg/ml L-arabinose. Cell cultures were incubated at 30°C ON with 250 rpm unless 
otherwise noted. 
 
Table 4: Overview of plasmids used for protein expression. 
Plasmid name Leader scTCR/scFv Co-expression Expression strainsa 
pPphOx-GFP PelB scFv anti-phOx  XB, XG, RB 
pT1phOx-GFP TorA1 scFv anti-phOx  XG 
pT2phOx-GFP TorA2 scFv anti-phOx  XB, XG, RB, BL 
pPphOx-GFPFN PelB scFv anti-phOx FkpA XB, RB 
pT2phOx-GFPFN TorA2 scFv anti-phOx FkpA XB, RB 
pPNIP-GFP PelB scFv anti-NIP  XB 
pPscTCR-GFP PelB scTCR  XB, XG, RB 
pT1scTCR-GFP TorA1 scTCR  XB, XG 
pT2scTCR-GFP TorA2 scTCR  XB, XG, RB 
pD1scTCR-GFP DsbA1 scTCR  XB 
pD2scTCR-GFP DsbA2 scTCR  XB 
pD3scTCR-GFP DsbA3 scTCR  XB 
pPscTCR-GFPFN PelB scTCR FkpA XB, RB 
pT2scTCR-GFPFN TorA2 scTCR FkpA XB, RB 
a Expression hosts abbreviations: XB – XL-1 Blue, XG – XL-1 Blue pGro7, RB – Rosetta Blue (DE3) pLysS and BL – BL21 
(DE3) 
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3.4.3 Cell fractionation 
Cell materials were normalized according to OD600nm and centrifuged at 4500 rpm for 15 
minutes at 4°C. 1 ml supernatant was transferred to a 1.5 ml eppendorf tube, centrifuged at 
13000 rpm for 10 minutes at 4°C and 750µl supernatant was transferred to a new 1.5 ml 
eppendorf tube and stored at 4°C (fraction I, medium fraction). The cell pellet was 
resuspended in 490 µl ice-cold sucrose solution (20% sucrose, 50 mM Tris/HCl pH 8.0 and 1 
mM EDTA pH 8.0) together with 5µl lyzosyme (100 mg/ml in 50 mM Tris/HCl pH 8.0) and 
5 µl RNaseA (10 mg/ml in Tris/HCl pH 8.0). The resuspended pellet was transferred to a new 
1.5 ml eppendorf tube and incubated for 1 hour at 4°C with rotation. The cells were pelletted 
by centrifugation at 13000 rpm for 5 minutes at 4°C. The supernatant was transferred to new 
1.5 ml eppendorf tube, centrifuged at 13000 rpm for 10 minutes at 4°C and 450µl supernatant 
was transferred to a new 1.5 ml eppendorf tube and stored at 4°C (fraction II, soluble 
periplasmic fraction). Residual liquid was removed from the cell pellet and the cells were 
resuspended in 475 µl 0.1 M Tris/HCl pH 8.0. 167 µl 4xSDS was thoroughly mixed with the 
cell solution and stored at 4°C (fraction III, cytoplasmic fraction). All fractions were finally 
stored at -20°C.  
 
3.5 Analysis of expression level, subcellular 
localization and fluorescence 
3.5.1 SDS-PAGE 
Samples of expression culture or fractions were investigated by sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE). Samples were mixed with proportionate 
amounts of 4xSDS. The samples and 10 µl Prestained Protein Marker Broad Range (7-175 
kDa) (NEB) were heated at 95°C for 5 minutes prior to loading on a 4-12% Bis-Tris XT 
Precast gel (BioRad). The gel was run at 140 V for 1 hour and 45 minutes.  
 
3.5.2 Coomassie staining 
For visualization of the proteins in. The gel was washed 2 x 5 minutes in dH2O, stained with 
Bio-Safe Coomassie Stain (BioRad) for 1 hour at RT with agitation, followed by washing 1 
hour in dH2O to visualize the protein bands. Pictures were taken with normal light using 
BioDoc-It™ Transiluminator system (UVP). 
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3.5.3 Western blot analysis 
Western blot analysis was performed by semi-dry blotting. Samples separated on SDS-PAGE 
gel was blotted on to polyvinylidine fluoride membrane (Millipore) in a Trans-Blot SD Semi-
Dry Transfer cell (Bio-Rad) in Tris/glycin buffer (25mM Tris, 192mM glycine, 20% 
methanol, pH 8.3). The apparatus was assembled and run at 25 V for 30 minutes. The 
membrane was blocked in 4% skimmed milk in PBST (PBS with 0,05% Tween 20) for 1.5 
hours at RT or ON at 4°C, followed by washing 3 times for 5 minutes in PBST. Incubation 
with immunodetection reagents was performed in 4% skimmed milk in PBST for 1.5 hours at 
RT or ON at 4°C. The membrane was washed 3 times for 5 minutes in PBST after each 
incubation. Immunodetection of GFP was performed by incubating with anti-GFP Ab 
(Abcam) diluted 1:2000, followed by SA-HRP (Amersham) diluted 1:5000. Immunodetection 
of the His6-tag was performed by incubating with anti-His-6-tag (C-term) Ab (Invitrogen) 
diluted 1:5000, followed by incubation with anti-mouse IgG-HRP Ab from sheep 
(Amersham) diluted 1:7000. Immunodetection of GroEL was performed by incubating with 
rabbit anti-GroEL Ab (Sigma) diluted 1:10000, followed by incubation with donkey anti-
rabbit IgG Ab(Amersham) diluted 1:50000. Immunodetection of FkpA was performed 
incubating with anti-Flag M2-HRP Ab (Sigma) diluted 1:7000. Immunodetection of scFv 
anti-phOx was performed by incubation with rabbit anti-human lambda L-chain AB (Dako) 
diluted 1:4000, followed by incubation with donkey anti-rabbit IgG HRP Ab (Amersham) 
diluted 1:8000. When more than one immunodetection was performed on a membrane, it was 
incubated covered in Restore Western Blot Stripping Buffer (Thermo) for 30 minutes at 37°C 
to strip for detection reagents. Development of the western blots was performed incubation 
for 5 minutes in 5 ml Super Signal West Pico Lumino Enhancer Solution (Pierce) mixed with 
5 ml Super Signal West Pico Stable Peroxide Solution (Pierce) and finally exposure of the 
membrane to Kodak BioMax MR film in a film cassette. The film was developed in an 
Optimax X-Ray Film Processor (PROTEC). 
 
3.5.4 Qualitative analysis with fluorescence microscopy 
Cell material was normalized according to OD600nm and centrifuged 4500 g for 5 minutes at 
RT. Supernatants were discarded and the pellets gently resuspended in 1 ml PBS followed by 
centrifugation for 5 minutes at 4500 g at RT. The pellet was resuspended in a final volume of 
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500µl PBS. 2 µl cells were applied on a microscope slide and a cover slide was put on top. 
Pictures were taken using an Axioplan 2 Imaging fluorescence microscope (Zeiss) with filter 
8 for fase contrast pictures (20 ms) and filter 2 (FITC-filter) for fluorescence pictures (100 
ms). 
 
3.5.5 Quantitative analysis of fluorescence with Victor fluorometer 
Cell material was normalized and washed as described in Section 3.5.4. 100 µl cells or 100 µl 
recombinant GFP (Clonetech) (10 µg/ml) diluted in PBS was added to FluoroNunc 96-well 
plates, black (Nunc). Fluorescence detection in the plate was performed with a Victor 1420 
Multilabel counter (Perkin Elmer) using the Fluorometry protocol at 485nm/535nm 1.0 sec. 
Triplicate of each sample was measured, however the variation within these measurements 
were less than 5%, and typically much smaller. Hence, average of the three samples is shown 
without standard deviations.  
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4 Results 
4.1 Construct design 
The Ig domain is dependent on disulfide bridge formation to obtain a functional 
conformation. Therefore, the three scaffolds chosen here, the scTCR and the scFvs with anti 
hapten specificity for NIP and phOx, denoted NIP and phOx, are targeted for periplasmic 
expression by a pelB leader. Due to differences in their solubility, the scTCR, NIP and phOx 
represents three different expression profiles in E. coli; only cytosolic; cytosolic and 
periplasmic; cytosolic, periplasmic and medium, respectively. The ultimate goal was to make 
a screening platform. These three scaffolds were chosen as “probes” and genetically fused to 
GFP to take advantage of the fluorescent properties of GFP in quantitative screening. To 
explore whether periplasmic expression of scTCR-GFP fusions could be obtained, three 
translocation mechanisms were compared using both the Sec- and Tat-pathways. Therefore, 
in addition to the pelB leader, the DsbA and TorA leader peptides were utilized for 
periplasmic targeting.  
 
 
Figure 6: Schematic overview of key elements in the expression vector. The size of the elements in the figure is not scaled in 
proportion to sequence length. 
 
4.1.1 Cloning strategy for the TorA and DsbA leader 
The DsbA signal sequence targets polypeptides to the periplasm through the co-translational 
SRP-dependent secretory pathway and thereby prevents polypeptides from folding in the 
cytoplasm (Schierle, Berkmen et al. 2003). The TorA signal sequence targets proteins to the 
Tat-translocator for transport of folded or partially folded domains to the periplasm(Berks, 
Palmer et al. 2005). Premature folding of GFP in the cytoplasm should therefore not impede 
translocation by the TorA leader.  
 
37 
 
The parental pHOG vector used for protein expression in the current study contains RE-based 
cassettes, which are easily interchanged between the different constructs (Kipriyanov, 
Moldenhauer et al. 1997). The signal peptide is coded for in the 3’-end of the EcoRI/NcoI 
cassette (as shown in Figure 6).  
 
Ineffective leader sequence removal after protein translocation may negatively affect the 
functionality of the mature polypeptide and the aa positions flanking the protease cleavage 
site is known to significantly influence the efficiency of the proteolysis (Shen, Lee et al. 
1991). Therefore, the transition (the residues in the close vicinity of the interface between the 
signal sequence and the protein of interest) is crucial for functional transport of proteins. 
Hence, different transitions between the signal sequences chosen in the current study and the 
downstream scTCR cassette were tested in silico by SignalP 3.0 (Bendtsen, Nielsen et al. 
2004) for the probability of 1) signal peptide recognition, 2) signal peptide cleavage 
efficiency and 3) cleavage site, to examine whether the new leader sequences could be 
designed compatible with the cassette system. 
 
 
TorA leader design 
A previous study isolated a gain-of-function mutant of the TorA leader (TorAB7) that shows 
a 6-fold increase in periplasmic expression of GFP compared to the wild type TorA leader 
(DeLisa, Samuelson et al. 2002). In silico analysis of the TorAB7 sequence fused directly to 
the scTCR sequence yielded low signal peptide and cleavage probability scores (Table 5) and 
was therefore not expected to be functional. In contrast, the TorAB7 sequence in context of its 
native partner, TorA, yielded a high probability score for signal sequence recognition and 
cleaving after position 39, which is the native cleavage site (Table 5).  
 
Therefore, a possible strategy for designing a functional leader was to add residues from the 
TorA protein between the TorAB7 leader and the scTCR. Two sequences with different 
transitions were chosen for in vivo analysis and the leader sequences were named TorA1 and 
TorA2 (shown in Figure 7). To ensure that the resulting leader sequences would be 
functionally interchangeable with the pelB leader in other constructs in the expression system, 
the TorA1 and TorA2 leaders were analyzed in silico in fusion to scFv anti-phOx and anti-
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NIP. This analysis gave similar probability scores and cleavage site as the scTCR (data not 
shown). The TorA1 and TorA2 leaders are showed in Figure 7. 
 
The primer TorAB7_EcoRI_new (shown in Table 2) was designed to contain the stretch from 
the EcoRI site to the start of the leader peptide as a 5’-tag, in addition to the annealing to the 
5’ end of TorAB7 in pB7G. The primers TorAB7_1NcoI and TorAB7_2NcoI (shown in 
Table 2) were designed to anneal to the 3’ end of the TorAB7 signal sequence and contain the 
respective transistion sequence and the NcoI RE site as a 5’-tags. 
 
DsbA leader design 
Based on a previous study (Steiner, Forrer et al. 2006), the DsbA leader sequence was chosen 
for co-translational translocation via the SRP-dependent pathway. The signal sequence was 
obtained from SwissProt (P0AEG4) and analyzed in fusion to scTCR in silico as previously 
described in the TorA design. Important considerations were peptide cleavage and whether 
the NcoI RE site could be preserved. Three sequences with different transistions were chosen 
for in vivo analysis. The chosen DsbA1, DsbA2 and DsbA3 leaders are shown in Figure 7. All 
three were analyzed in silico in fusion to scFv anti-phOx and anti-NIP and gave similar 
probability scores as the scTCR (data not shown). Three EcoRI/NcoI cassettes containing 
each of the DsbA leaders were ordered as plus and minus strand oligonucleotides (Table 2).  
 
 
Figure 7: Overview of the leader sequences.”|”represents predicted cleavage site; aa in red are mutated or additional aa. 
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Table 5: In silico analysis of transitions between leader peptides and scTCR using the hidden Markov model (HMM) in 
SignalP3.0 (http://www.cbs.dtu.dk/services/SignalP/). This analysis was performed by Geir Åge Løset. 
Input Signal peptide 
probability scorea 
Cleavage site 
probability scoreb 
Predicted 
cleavage sitec 
TorAB7-scTCR 0,056 0,030 37-38 
TorA-TorA 0,963 0,950 39-40 
TorAB7-TorA 0,941 0,929 39-40 
TorAB7-AMA-scTCR 0,650 0,556 39-40 
TorAB7-AAMA-scTCR 0,829 0,772 39-40 
TorAB7-AAQMA-scTCR 0,874 0,863 39-40 
TorAB7-AAQAMA-scTCR 0,890 0,854 39-40 
TorAB7-AAQAAMA-scTCR 0,935 0,910 39-40 
TorAB7-AAQAAMAT-scTCR 0,935 0,906 39-40 
DsbA-scTCR 1,000 0,757 19-20 
DsbA-A-scTCR 1,000 0,900 19-20 
DsbA(S18M)-scTCR 1,000 0,964 19-20 
DsbA(S18M)-A-scTCR 1,000 0,993 19-20 
DsbA-AMA-scTCR 1,000 0,973 22-23 
DsbA-MA-scTCR 1,000 0,995 21-22 
a Probability of the sequence containing a signal peptide. b Probability of cleavage at the predicted cleavage site. c Predicted 
cleavage site between indicated residues. 
 
Table 6: Over view of proteins and their theoretical molecular weights (MW).  
Protein Leader scTCR/scFv MWa preprotein MWa without leader 
PphOx-GFP PelB scFv anti-phOx 59kDa 57kDa 
T1phOx-GFP TorA1 scFv anti-phOx 61kDa 57kDa 
T2phOx-GFP TorA2 scFv anti-phOx 61kDa 57kDa 
PNIP-GFP PelB scFv anti-NIP 59kDa 56kDa 
PscTCR-GFP PelB scTCR 59kDa 56kDa 
T1scTCR-GFP TorA1 scTCR 61kDa 57kDa 
T2scTCR-GFP TorA2 scTCR 61kDa 57kDa 
D1scTCR-GFP DsbA1 scTCR 58kDa 56kDa 
D2scTCR-GFP DsbA2 scTCR 59kDa 56kDa 
D3scTCR-GFP DsbA3 scTCR 59kDa 56kDa 
PphOx+c-myc+His6 PelB scFv anti-phOx 32kDa 30kDa 
FkpA(+FLAG)   30kDa 27kDa 
GroEL   ~60kDab NA 
rGFP   ~27kDac NA 
GFP+c-myc+His6    29kDa 
PphOx PelB scFv anti-phOx 29 kDa 27 kDa 
a MW is calculated using http://www.expasy.ch/tools/pi_tool.html. b GroEL MW was adopted from Takara. c Recombinant 
GFP MW was adopted from Clonetech. 
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4.2 Comparison of YFP and GFP constructs 
The YFP fluorophore encoded in the parental pHOG plasmid was exchanged with a gene 
encoding a mutant GFP fluorophore developed to yield increased fluorescence with standard 
FITC filters. This particular GFP mutant also exhibits increased functional expression in 
prokaryotic hosts (Cormack, Valdivia et al. 1996). To evaluate differences in performance, 
PphOx-GFP and PphOx-YFP was expressed in E. coli XL-1 Blue using identical conditions 
followed by whole cell fluorescent imaging. The results in Table 7 showed that the GFP 
construct yielded increased fluorescence as compared to the YFP construct when using the 
FITC-filter. The GFP vector was therefore chosen for further use in the current study. 
 
4.3 Expression characteristics of scTCR and scFvs 
 
The expression profile of the scTCR and the scFvs phOx and NIP, all with pelB leader, were 
validated by expression in XL-1 Blue followed by fractionation, SDS-PAGE and western 
bloting with anti-c-myc detection. Figure 8 shows that phOx was detected in the medium, 
periplasmic and cytosolic fractions, NIP was detected in the periplasmic and cytosolic 
fractions and the scTCR was only detected in the cytosolic fraction. 
 
 
Figure 8: Expression of scTCR and the scFvs anti-phOx and anti-NIP followed by fractionation, SDS-PAGE and western 
bloting by anti-c-myc detection. M – Medium fraction; P – Periplasmic fraction; C – Cytosolic fraction. This experiment was 
performed by Geir Åge Løset. 
  
41 
 
Table 7: Fluorescence imaging of PphOx-GFP and PphOx-YFP expressed in XL-1 Blue. 
Exposure 
time 
PphOx-YFP PphOx-GFP XL1-Blue 
20ms 
50ms 
75ms 
100ms 
 
150ms 
200ms 
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4.4 Expression characteristics of scTCR-GFP and 
scFv-GFP fusions in XL-1 Blue 
To analyze the expression profile of the three entities phOx, NIP and scTCR in fusion to GFP 
and to investigate the expression characteristics of the scTCR-GFP fusion with different 
leaders, the constructs were expressed in XL-1 Blue with standard expression conditions. 
 
4.4.1 Effect of leader on total expression level  
The total expression levels were analyzed by SDS-PAGE of normalized whole cell cultures 
followed by western blot (Figure 9). As seen in Figure 9, both the scFv-GFP fusions with 
pelB leader were detected at ~58 kDa, which is close to the theoretical predicted size. Anti-
His6 (Figure 9 A) and anti-GFP (Figure 9 B) were used as detection reagents. One and two 
weak bands, respectively, were shown which indicates the presence of cleavage products at 
~30 kDa of phOx-GFP with pelB leader. This is about half the size of the full length fusion 
protein. Since the two entities that compose the fusion protein have approximately the same 
size, it indicates a cut in the linker region between the two modules.  
 
For the scTCR-GFP fusions there were large differences in expression level between the 
various leader constructs. The pelB-construct is detected at expected size with an expression 
level similar to PNIP-GFP. Both the TorA-constructs are detected at approximately predicted 
size with expression levels far greater than that seen for pelB constructs. Some higher 
aggregates, possibly dimers, and bands at ~40kDa were also detected for the TorA-constructs. 
In contrast, of the three DsbA-constructs only the D1scTCR-GFP was detected with anti-His6 
(Figure 9 A) and none of the DsbA-constructs were detected with anti-GFP (Figure 9 B). The 
detected of D1scTCR-GFP with anti-His6 might have been a result of overflow from the 
neighboring T2scTCR-GFP. 
 
In summary, these results indicate that the signal peptide sequence had a profound effect on 
the total expression level of fusion proteins with TorA giving the highest level, pelB giving an 
intermediate level and DsbA not giving any detected level. The most striking observation was 
the very low expression levels seen with the DsbA leader construct.  
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Figure 9: Normalized samples of cell cultures with expressed protein in XL1-Blue analyzed by SDS-PAGE and western blot. 
(A) Detection by anti-His6 (Invitrogen) and anti-mouse IgG-HRP Ab from sheep (Amersham). (B) Detection by anti-GFP 
(Abcam) and SA-HRP (Amersham). 
 
4.4.2 Effect of leader on subcellular localization  
To investigate the effect of leader peptides on subcellular localization of scTCR-GFP fusions 
and the subcellurlar localization of the scFv-GFP fusions, normalized amounts of expression 
culture were fractionated and the medium (M), periplasmic (P) and cytoplasmic (C) were 
analysed by SDS-PAGE and western bloting (Figure 10).  
 
Figure 10 shows that all three fusion proteins with pelB leader were mainly detected in the 
cytoplasmic fraction. Small amounts of scFv-GFP fusions transported to the periplasm and 
cleaved. Furthermore, neither the two TorA leaders, nor the three DsbA leaders increased the 
periplasmic or medium localization of the scTCR-GFP fusion proteins. Scrutiny of the blots 
revealed that PhOx-GFP in the cytoplasmic fraction is at the size of full length fusion 
proteins, with a smear of aggregated proteins at larger size and some degraded or cleaved 
proteins at smaller size. In the periplasmic and medium fractions, phOx-GFP detection with 
anti-GFP showed two bands at ~30kDa and ~34kDa (Figure 10 A and B), while detection 
with anti-His6 only showed one band at ~34kDa (Figure 10 C and D). In the periplasmic 
fraction PNIP-GFP was only detected by anti-GFP in Figure 10 B with a band at ~30kDa. 
This indicated that phOx-GFP and NIP-GFP were transported to the periplasm where 
cleavage and possibly degradation took place.  
 
Figure 10 A and C showed that the scTCR-GFP fusion protein were not in the medium or 
periplasmic fractions with anti-GFP or anti-His6 detection, regardless of leader peptide. The 
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cytoplasmic fractions of scTCR-GFP in Figure 10 B and C, detected with anti-GFP and anti-
His6 Abs, respectively, showed a similar expression pattern as for the whole cell fractions in 
Figure 9: high expression level with TorA1 and TorA2 leaders, mainly of full length fusion 
proteins but also some higher aggregates and cleavage/degradation products; medium 
expression level with PelB leader of full length protein and with some higher aggregates and 
minor amounts of cleavage/degradation products; the DsbA-constructs are detected with a 
very low expression level in contrast to Figure 9 where no protein is detected. The low yield 
of detected DsbA constructs confirms functional open reading frames and can be explained by 
up concentration that occurred during fractionation. 
 
Empty XL1-Blue cells show no detectable proteins with anti-His6 or anti-GFP detection in 
Figure 10 A or B. However, in Figure 10 B a background detection at ~28kDa with anti-GFP 
is seen in all cytoplasmic fractions including the empty XL1-Blue cells and this was observed 
occasionally using the polyclonal anti-GFP ab. The scFv anti-phOx in pHOG with a PelB 
leader was expressed in parallel as a control since this protein is expressed in all three 
fractions with a detectable His6-tag as seen in Figure 10 D. 
 
4.4.3 Effect of leader on relative fluorescence in cells 
To analyze if functionally folded protein is expressed, the relative fluorescence of cells was 
measured. There is a strong correlation between the folding state of the fusion partner and the 
GFP entity, as assessed by the fluorescence of the GFP (Zhang, Cantor et al. 2005). Thus, as 
the GFP is expressed as a C-terminal reporter in our fusion proteins, it is reasonable to assume 
that the N-terminal fusion partner has to fold correctly for the fusion proteins to exhibit 
fluorescence. Cells harboring the fusion proteins were therefore examined for their 
fluorescent properties.  
 
After expression, normalized samples of cells were washed and relative fluorescence 
measured. Empty XL1-Blue cells were used to indicate autofluorescence in the bacteria and a 
standard of 10 µg/ml rGFP was used as a positive control. Triplicate of each sample was 
applied to the microtiter plate and measured in relative fluorescent units (RFU). The average 
of each sample is presented in Figure 11 without standard deviation as the variation within the 
triplicates was less than 5%.  
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Figure 10: Expression analysis of subcellular localization in XL-1 Blue. Fraction M – medium, P – periplasm, C – 
cytoplasm. XL-1 Blue is cells without plasmid, pHOG-phOx is the parental scFv anti-phOx plasmid without GFP, rGFP is 
recombinant GFP. Detection with anti-GFP (A and B) or anti-His6 (C and D). (A) Medium and soluble periplasmic fractions 
of scTCR-GFP with TorA and DsbA leaders and all fractions of phOx- and NIP-GFP. (B) Cytoplasmic fractions of scTCR-
GFP with TorA and DsbA leaders and all fractions of phOx- and NIP-GFP. (C) Medium and soluble periplasmic fractions of 
scTCR-GFP with TorA and DsbA leaders and all fractions of phOx- and NIP-GFP. (D) Cytoplasmic fractions of scTCR-GFP 
with TorA and DsbA leaders and all fractions of phOx- and NIP-GFP. 
 
 
Figure 11: The relative fluorescence of normalized samples of cells, washed in PBS and analyzed in black 96-well microtiter 
plates  using a Victor 1420 Multilabel counter (Perkin Elmer) using the Fluorometry protocol at 485nm/535nm 1.0 sec. The 
effect of leader peptide on scTCR-GFP fluorescence and characterization of the fluorescence of PphOx-GFP and PNIP-GFP. 
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As shown if Figure 11, scTCR-GFP with pelB or DsbA leaders and PNIP-GFP were 
measured to a RFU level similar to the autofluorescence measured in XL-1 Blue. Hence, these 
fusion proteins were not correctly folded. PphOx-GFP and scTCR-GFP with TorA leaders 
showed a 7 and 5 fold higher RFU, respectively. 
  
4.4.4 Effect of leader on fluorescence microscopy of cells 
To further investigate the fluorescent properties, cells were examined for the fluorescence 
distribution. Punctuated fluorescence has been shown to be an indication of periplasmic 
localization compared to evenly distributed fluorescence being a property of proteins 
expressed in the cytosol (Casey, Coley et al. 2000). The constructs were expressed in XL-1 
Blue and cells washed prior to imaging.  
 
The fluorescence images, presented in Table 8, visualize the differences in RFU measured and 
presented in Figure 11: PphOx-GFP, T1scTCR-GFP and T2scTCR-GFP show fluorescent 
properties while the other constructs, PNIP-GFP, PscTCR-GFP, D1scTCR-GFP, D2scTCR-
GFP and D3scTCR-GFP, do not show fluorescence in comparison to the autofluorescence of 
empty XL-1 Blue cells. All the three fluorescent constructs display an uneven distribution of 
the fluorescence throughout the cell, with PphOx-GFP being slightly more punctuated than 
T1scTCR-GFP and T2scTCR-GFP.  
 
In summary, the results so far show that the DsbA leader constructs were expressed at very 
low levels and these were therefore not investigated further. Both the phOx- and NIP-GFP 
fusions with pelB leader were detected as cleaved protein in the periplasm. However, of the 
two, the phOx fusion showed the most desirable expression characteristics and were 
examined further, whereas the NIP-GFP construct was excluded from the rest of this study. 
 
Despite fluorescence of both phOx-GFP and scTCR-GFP with TorA leaders, the subcellular 
analysis showed that phOx-GFP is cleaved when translocated and the scTCR-GFP constructs 
were only localized in the cytosol. Hence, optimalization is needed to produce functional full 
length fusion proteins. 
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Table 8: Fluorescence imaging of constructs expressed in XL-1 Blue using an Axioplan 2 Imaging fluorescence microscope 
(Zeiss) with filter 8 for fase contrast pictures (20 ms) and filter 2 (FITC-filter) for fluorescence pictures (100 ms). 
Phase contrast 20 ms FITC filter 100 ms Phase contrast 20 ms FITC filter 100 ms 
PphOx-GFP PNIP-GFP 
PscTCR-GFP T1scTCR-GFP 
T2scTCR-GFP D1scTCR-GFP 
D2scTCR-GFP D3scTCR-GFP 
XL-1 Blue 
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4.5 Effect of chaperones 
 
4.5.1 Over-expression of GroEL-GroES 
To examine the effect of over-expressing cytosolic folding assistance, expression was 
performed in XL-1 Blue pGro7 which harbors inducible over-expression of the cytosolic 
chaperones GroEl-GroES (Nishihara, Kanemori et al. 1998). 
 
The TorA leader directs folded or partially folded domains to the Tat-pathway for 
translocation to the periplasm. Hence, TorA constructs are putative substrates of GroEL-
GroES. Therefore, phOx-GFP and scTCR-GFP fusions with pelB, TorA1 and TorA2 leaders 
were expressed in XL-1 Blue pGro7. Proteins were expressed as previously described and 
performed in two parallels to test two different induction start points of GroEL and GroES 
expression: A – induction when ONC was reinoculated for expression and B – induction 
simultaneously as IPTG induction of fusion protein expression. Empty XL-1 Blue pGro7 cells 
were grown in triplicate as controls and validation of GroEL-GroES expression with 
induction A, B and an additional C without induction. 
 
Validation of GroEL-GroES over-expression 
To validate GroEL over-expression, analysis was performed of a coomassie stained SDS-
PAGE gel and a western blot detected with anti-GroEL Ab.  
 
The coomassie stained SDS-PAGE gel showed clear bands of GroEL expression (~60kDa) in 
the cytosolic fractions when expression was induced (A and B), but only endogenous 
chaperone levels without induction (C) (shown in Figure 12 A). The bands and expression 
levels were validated as GroEL by western blot analysis by detected with anti-GroEL Ab, 
hence confirming the chaperone over-expression (shown in Figure 12 B). 
 
The low levels of GroEL detected in the medium and periplasmic fractions originates from 
cell lysis and overflow during the sample application to the gel. However, due to high 
sensitivity of the detection it represents minute amounts of protein. 
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Effect of GroEL-GroES 
To validate effect of GroEL-GroES over-expression on periplasmic yield of scTCR- and 
phOx-GFP fusions with pelB, TorA1 and TorA2 leader were expressed in XL-1 Blue with 
over-expression of the chaperones. Normalized cell samples were fractionated and analyzed 
by SDS-PAGE and western bloting with anti-His6 and anti-GFP detection. 
 
Figure 13 shows that the scTCR-GFP constructs were not transported to the periplasm with 
pelB or TorA leaders when GroEL-GroES is over-expressed, as no bands are visible. GroEL-
GroES had a negative effect on transport of phOx-GFP with pelB leaders as no periplasmic 
protein is detected. However, bands of cleaved periplasmic fusion protein at ~32kDa was 
detected for phOx-GFP with TorA1 and TorA2 leaders, as previously observed with pelB 
leader without chaperone over-expression. Hence, GroEL-GroES had no effect on periplasmic 
expression of scTCR-GFP fusions, independent of leader, or phOx-GFP fusions with TorA 
leaders. However, over-expression of GroEL-GroES seems to impede the transport of phOx-
GFP fusions with pelB leader to the periplasm. 
 
Collectively, the data so far showed a more favorable expression profile for the TorA2 leader 
constructs as compared to the TorA1 leader constructs. Thus, the TorA1 constructs were 
excluded from further analysis. 
 
Figure 12: Coexpression of GroEL in XL-1 Blue pGro7 cells. The GroEL/ES expression is induced with L-arabinose at two 
different timepoints: A – when ONC is reinoculated to start the expression culture (OD600nm~0.1), B – simultaneously as 
IPTG induction. C is without induction. (A) Fractions of XL-1 Blue pGro7 cells separated on SDS-PAGE and coomassie 
stained gel. (B) Fractions of XL-1 Blue pGro7 cells separated on SDS-PAGE and detection on western blot with anti-GroEL. 
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Figure 13: Expression in XL-1 Blue with coexpression of GroEL/ES, periplasmic fractions. The GroEL/ES expression is 
induced with L-arabinose at two different timepoint: A – when ONC is reinoculated to start the expression culture 
(OD600nm~0.1), B – simultaneously as IPTG induction. C is without induction. (A) Fractions separated on SDS-PAGE and 
analyzed by western blot with anti-GFP. (B) Fractions separated on SDS-PAGE and analyzed by western blot using anti-
His6. 
4.5.2 Over-expression of FkpA 
 
Over-expression of the periplasmic chaperone FkpA  rescues soluble periplasmic expression 
of the scTCR clone in this study (Gunnarsen, Lunde et al. submitted). To investigate the effect 
of FkpA over-expression, phOx- and scTCR-GFP fusions with pelB and TorA2 leader were 
expressed with and without FkpA over-expression. 
 
Effect of FkpA on total expression level 
To investigate the effect of FkpA over-expression on total expression level, normalized cell 
samples from protein expression in XL-1 Blue were analyzed using SDS-PAGE and Western 
blot as shown in Figure 14. 
 
Expression of phOx-GFP with pelB leader yielded similar expression levels independent of 
FkpA over-expression. However, expression of phOx-GFP with TorA2 leader showed a 
reduced expression level when FkpA was over-expressed. Furthermore, expression of scTCR-
GFP with either pelB or TorA leader showed litte effect on total expression level when FkpA 
was over-expressed. Hence, FkpA seems to have no effect on total expression level, with one 
exception where the effect was negative. 
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Figure 14: SDS-PAGE and Western blot of normalized cell samples from expression of phOx- and scTCR-GFP fusions with 
PelB (P) and TorA2 (T2) leader, with and without FkpA co-expression, in XL-1 Blue (X) and Rosetta Blue (DE3) pLysS (R). 
(A) Developed with anti-His6.  (B) Developed with anti-GFP. 
 
 
Figure 15: SDS-PAGE and western blot of normalized periplasmic fractions from expression of phOx- and scTCR-GFP 
fusions with pelB and TorA2 leader, with and without FkpA over-expression, in XL-1 Blue and Rosetta Blue (DE3) pLysS. 
(A) Detected with anti-GFP. (B) Detected with anti-His6. 
 
Figure 16: SDS-PAGE and western blot of normalized periplasmic fractions from expression of phOx- and scTCR-GFP 
fusions with pelB and TorA2 leader, with and without FkpA over-expression, in XL-1 Blue and Rosetta Blue (DE3) pLysS, 
detected with anti-Flag M2-HRP Ab. 
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Effect of FkpA on subcellular localization 
To further investigate the effect of FkpA over-expression on subcellular localization, 
normalized periplasmic fractions from protein expression were analyzed using SDS-PAGE 
and western blot, as shown in Figure 15.  
 
Expression of scTCR-GFP fusions did not yield periplasmic protein regardless of leader and 
over-expression of FkpA. Expression of phOx-GFP with pelB and TorA leaders resulted in 
detection of a cleaved product ~32 kDa in size in the periplasm, similar to what have been 
observed previously. However, the over-expression of FkpA reduced the periplasmic yield of 
both these construct. Periplasmic over-expression of FkpA was validated in Figure 16 for the 
constructs expressed in XL-1 Blue. 
 
In summary, neither the scTCR-GFP nor the phOx-GFP construcs yielded periplasmic 
expression of full length fusion protein. 
 
Effect of FkpA on relative fluorescence 
To further investigate the effect of FkpA on the fluorescent properties of the constructs in XL-
1 Blue, cells were washed and relative fluorescence measured. 
 
Figure 17  shows the effect of FkpA on relative fluorescence in cells. For PscTCR-GFP and 
T2scTCR-GFP expression, the measurements showed similar levels of relative fluorescence 
with and without FkpA and therefore it was reasonable to believe that co-expression of FkpA 
had no effect these two construct. T2phOx-GFP expression in XL-1 Blue showed a more than 
four-fold reduction in fluorescence when FkpA is co-expressed. Expression of PscTCR-GFP 
gave a moderate increase in relative flourescende. 
 
Effect of FkpA on fluorescence imaging 
Fluorescence imaging of the constructs showed that FkpA did not notably increase the 
fluorescence or alter the properties in XL-1 Blue, as seen in Table 9. 
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Figure 17: The relative fluorescence of normalized samples of cells, washed in PBS and analyzed in black 96-well microtiter 
plates  using a Victor 1420 Multilabel counter (Perkin Elmer) using the Fluorometry protocol at 485nm/535nm 1.0 sec. The 
effect of co-expression of FkpA for each construct in each expression host, comparing with and without FkpA. XB – XL-1 
Blue, RB – Rosetta Blue. 
 
4.6 Effect of expression host 
Expression of heterologous proteins in E. coli is challenging for many reasons and using host 
strains customized for protein expression has been one strategy.  
 
4.6.1 Expression in Rosetta Blue (DE3) pLysS 
Rosetta Blue (DE3) pLysS is a strain that contains extra tRNA genes for expression of 
proteins with codons rarely used in E. coli. To investigate the effect of extra tRNAs, phOx- 
and scTCR-GFP fusions with pelB and TorA2 leader were expressed with and without FkpA 
over-expression, were expressed in XL-1 Blue and Rosetta Blue (DE3) pLysS. 
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Table 9: Fluorescence imaging of constructs expressed in XL-1 Blue or Rosetta Blue, with and without FkpA. 
XL-1 Blue 
Fase contrast                  FITC filter 
Rosetta Blue 
Fase contrast                         FITC filter 
PphOx-GFP 
T2phOx-GFP 
PphOx-GFPFN 
T2phOx-GFPFN 
PscTCR-GFP 
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T2scTCR-GFP 
PscTCR-GFPFN 
T2scTCR-GFPFN 
Cells 
 
 
Effect on total expression level 
To examine the effect of extra tRNAs on total expression level, normalized cell samples from 
protein expression were analyzed using SDS-PAGE and Western blot as shown in Figure 14. 
 
The phOx-GFP fusions with pelB leader showed similar total expression levels in XL-1 Blue 
and Rosetta Blue, independent of FkpA over-expression. Expression of phOx-GFP with 
TorA2 leader yielded a higher expression level in XL-1 Blue without FkpA, and contrary, a 
higher expression level in Rosetta Blue with FkpA.  
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For scTCR-GFP with pelB leader without FkpA, XL-1 Blue yielded a higher expression level 
than Rosetta Blue. However, scTCR-GFP with pelB leader and FkpA, showed a higher 
expression level in Rosetta Blue than in XL-1 Blue. Expression of scTCR-GFP with TorA2 
leader without FkpA showed similar expression levels in both strains. In contrast, expression 
of scTCR-GFP with TorA2 leader with FkpA showed a higher expression level in XL-1 Blue 
as no potein was detected in Rosetta Blue. 
 
In summary, expression in a host strain providing extra tRNAs for compensation of codon 
bias showed a variety of effects, depending on scaffold, leader and over-expression of FkpA. 
 
Effect on subcellular localization 
To further investigate the effect of extra tRNAs on subcellular localization, normalized 
periplasmic fractions from protein expression were analyzed using SDS-PAGE and western 
blot, as shown in Figure 15. Expression of scTCR-GFP fusions did not yield periplasmic 
protein regardless of leader, over-expression of FkpA and extra tRNAs. 
 
The effect of extra tRNAs on the periplasmic expression of phOx-GFP with pelB leader did 
not significantly alter the periplasmic expression levels, with or without FkpA. Also the 
periplasmic expression of phOx-GFP with TorA2 leader without FkpA showed similar 
periplasmic expression levels with and without extra tRNAs. However, the periplasmic 
expression of phOx-GFP with TorA2 leader with FkpA showed a significant increase when 
expressed with extra tRNAs. Further investigation of FkpA expression in Figure 16 showed 
that the periplasmic FkpA level was very small, hence the two constructs were not directly 
comparable. 
 
Effect on relative fluorescence in cells 
To further investigate the effect of extra tRNAs on the fluorescent properties of the 
constructs, cells were washed and relative fluorescence measured. Figure 18 showed that 
phOx-GFP with pelB and TorA2 leader, without FkpA, showed reduced fluorescence when 
expressed in Rosetta Blue with extra tRNAs. In contrast, the same constructs with FkpA 
showed an increase in fluorescence. However, the T2phOx-GFPFN construct in Rosetta Blue 
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did not show over-expression of FkpA in the periplasm and can not be directly compared to 
the same construct expressed in XL-1 Blue. 
 
 The scTCR-GFP fusion proteins did not show any great change in relative fluorescence, with 
the exception of scTCR-GFP with TorA2 leader which showed a reduced relative 
fluorescence when expressed with extra tRNAs.  
 
 
Figure 18: The relative fluorescence of normalized samples of cells, washed in PBS and analyzed in black 96-well microtiter 
plates  using a Victor 1420 Multilabel counter (Perkin Elmer) using the Fluorometry protocol at 485nm/535nm 1.0 sec. The 
effect of host strain during expression with each construct expressed in XL-1 Blue put up agains expression in Rosetta Blue.  
 
In Rosetta Blue, both phOx-GFP and scTCR-GFP, with pelB and TorA2, gave an increased 
relative fluorescence with the over-expression of FkpA. 
 
Effect on fluorescence imaging 
Fluorescence imaging of the constructs are presented in (Table 9). The images does not show 
any big difference in the fluorescent properties when extra tRNAs are expressed with the 
exception of T2phOx-GFP which show that more cells exhibit fluorescence when extra 
tRNAs are expressed. However, this is the previously mentioned construct which is not 
directly comparable due to lack of FkpA over-expression. In summary, expression of extra 
tRNAs did not yield periplasmic full length fusion proteins of neither phOx-GFP nor scTCR-
GFP constructs. 
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4.6.2 Expression in BL21 
To further investigate the possibility of obtaining full length periplasmic fusion protein, 
phOx-GFP with TorA2 leader was expressed in the host strain BL21 which is deficient in the 
lon and ompT proteases. 
 
The expression of phOx-GFP with TorA2 leader in BL21 showed a decrease in total 
expression level and periplasmic expression level compared to XL-1 Blue, as shown in Figure 
19 and Figure 20. Further, there was a decrease in relative fluorescence when expressed in 
BL21, as shown in Figure 21. Hence, no full length periplasmic fusion protein was obtained 
from expression in BL21. 
 
4.7 Effect of induction and expression temperature 
4.7.1 Induction versus no induction at 30°C 
Induction of protein expression has been shown to give increased periplasmic yield of scTCR 
(Gunnarsen, Lunde et al. submitted). Therefore, the fusion proteins were expressed in XL-1 
Blue with and without induction to investigate the effect of over-expression of fusion proteins 
versus expression at basal transcription, respectively. 
 
Effect on total expression level 
To investigate the effect of induction on total expression level, phOx-GFP with TorA2 and 
PelB leader, both with and without FkpA was expressed in XL-1 Blue with and without 
induction. Normalized cell samples from protein expression were analyzed using SDS-PAGE 
and Western blot. 
 
As seen in Figure 19, induction did not significantly affect the total expression level of any of 
the four constructs when expressed at 30°C, the standard expression temperature.  
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Figure 19: SDS-PAGE and Western blot of normalized cell samples from expression of of PphOx-GFP and T2phOx-GFP 
with and without FkpA in XL-1 Blue and T2phOx-GFP without FkpA in BL21 (A) Detection with anti-His6 and anti-mouse 
IgG-HRP Ab from sheep.  (B) Detection with anti-GFP and SA-HRP. 
 
Effect on subcellular localization 
To further examine the effect of induction of subcelluar localization, cells expressed at 30°C 
were fractionated and analyzed by SDS-PAGE and western blot, as shown in Figure 20.  
 
No full length protein was obtained for any of the constructs. However, when phOx-GFP was 
expressed with pelB, cleaved fusion proteins were mainly detected with induction, 
independen of FkpA. The pelB constructs that was not induced show a reduction of 
periplasmic cleaved protein.  
 
When phOx-GFP was expressed with TorA leader without FkpA, induction did not 
significantly affect the yield of cleaved protein in the periplasm. However, when expressed 
with FkpA, phOx-GFP with TorA leader showed a reduced yield of cleaved protein in the 
periplasm when not induced. 
 
Effect on relative fluorescence in cells 
The effect of induction was further investigated by measuring the relative fluorescence of 
cells with and without induction, as shown in Figure 21. Induction of constructs gave the 
highest relative fluorescence for phOx-GFP with pelB leader, both with and without FkpA. 
Expression of phOx-GFP with TorA leader, both with and without FkpA, obtained the highest 
relative fluorescence when not induced. 
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Figure 20: SDS-PAGE and Western blot of normalized periplasmic fractions from expression of PphOx-GFP and T2phOx-
GFP with and without FkpA in XL-1 Blue and T2phOx-GFP without FkpA in BL21. (A) Detection with anti-His6.  (B) 
Detection with anti-GFP. 
 
 
Figure 21: Effect of induction on relative fluorescence in cells. 
 
Effect on fluorescence imaging 
The effect of induction on the fluorescent properties of the cells was examined and the images 
are shown in Table 10. Induction seemed to be necessary for the phOx-GFP with pelB leader, 
with and without induction, to obtain fluorescent cells. None of the other constructs showed 
altered fluorescence. 
 
In summary, induction at standard expression temperature 30°C did not significantly alter the 
total expression level. Furthermore, not inducing over-expression of fusion protein did not 
yield full length periplasmic fusion protein.  
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4.7.2 Expression at 30°C versus 16°C 
A previous study has shown successful expression of periplasmic full length scFv-GFP fusion 
when performing the expression at 16 °C for 48 hours(Griep, van Twisk et al. 1999). 
Therefore, expression of the phOx-GFP fusions was tested by comparing 30°C ON to 16°C 
for 48 hours. 
 
Effect on total expression level 
Normalized samples of cell culture from protein expression were analyzed using SDS-PAGE 
and western blot as shown in Figure 19.  
 
The effect of total expression level is shown in Figure 19. Full length fusion proteins of 
phOx-GFP with PelB and TorA leader, with and without FkpA over-expression, were 
detected when expressed at 30°C with and without IPTG induction, and when expressed 
at16°C with induction only. Cleaved fusion proteins were detected when expressed with a 
TorA leader without induction, at both 16°C and 30°C. When inducing at 16°C, cleaved 
fusion protein was detected regardless of leader and FkpA over-expression. When inducing 
expression at 30°C, phOx-GFP with pelB leader, with and without FkpA, was detected at 
cleaved fusion protein size. Expression of phOx-GFP with TorA2 leader with induction at 
30°C was detected as a cleaved fusion protein without FkpA but not with FkpA over-
expression. 
 
Figure 19 B showed that application of the rGFP control to the SDS-PAGE gel gave overflow 
to the neighboring wells as a clear band is detected  at ~30 kDa for T2phOx-GFP (BL21) at 
16°C with induction, empty XL-1 Blue and empty BL21 cells. Due to limited number of wells 
in the gel, all the controls with XL-1 Blue and BL21 growth at 30°C and 16°C, with and 
without induction, with whole cell samples, periplasmic fractions and cytoplasmic fractions 
were analyzed by SDS-PAGE gels and western bloting as done for the expressions cultures. 
These western blots showed no protein expression with detection by anti-His6 or anti-GFP. 
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Effect on subcellular localization 
To further investigate the effect of incubation temperature, cells were fractionated and the 
periplasmic fractions analyzed using SDS-PAGE and Western blot, as shown in Figure 20. 
 
For the constructs expressed, no full length fusion protein was detected in Figure 20. Without 
FkpA expression, phOx-GFP with TorA2 leader was detected as cleaved fusion protein at ~32 
kDa at relatively high yields independent of expression temperature and induction. With 
FkpA over-expression, phOx-GFP with TorA2 leader was detected as cleaved fusion protein 
at ~32 kDa whithout induction at 30°C, and both with and without induction at 16°C. As 
previously observed, the expression level of phOx-GFP with TorA2 leader was reduced when 
FkpA is over-expressed. When phOx-GFP was expressed with pelB leader, cleaved fusion 
protein at ~32 kDa was detected when the cultures were induced, at 30°C and 16°C, and with 
and without FkpA. phOx-GFP expression with the pelB leader and without induction gave 
detection of cleaved fusion protein at ~32 kDa when FkpA was over-expressed at 30°C. 
Interestingly, when phOx-GFP with pelB leader was detected with anti-GFP in Figure 20 B, 
most of the detected cleaved protein was detected with doublet bands at ~30 kDa and ~32 
kDa while the anti-His6 detection only reveal one band. 
 
Figure 22 A shows overexposure of the blot of periplasmic fractions detected with anti-His6. 
The only band of full length fusion protein at ~60 kDa was detected for phOx-GFP with pelB 
leader expressed with FkpA over-expression at 30°C without induction. Under these 
conditions there was barely any detected cleaved fusion protein at 30 kDa. 
 
The His6-tag is located C-terminal in the fusion protein downstream of the GFP. The 
detection with anti-GFP and anti-His therefore only verify the presence of the C-terminal 
domain of the fusion protein. To detect the N-terminal domain of the scFv anti-phOx, the blot 
was incubated with rabbit anti-human lambda L-chain and donkey anti-rabbit IgG HRP and 
presented in Figure 22 B. Surprisingly, there was detection of bands at ~30 kDa when the 
phOx-GFP was expressed with pelB leader and not when expressed with TorA2 leader. When 
expressed with pelB leader, the scFv anti-phOx N-terminal entity was detected both with and 
without FkpA and when expressed at both 30°C and 16°C, with and without induction. This 
was surprising since the detection of the C-terminal entity with Abs in Figure 20 shows 
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highest expression levels with TorA2 leader. The expression of FkpA was verified by 
detection with anti-Flag M2-HRP in Figure 23. 
 
 
Figure 22: SDS-PAGE and Western blot of normalized periplasmic fractions from expression of PphOx-GFP and T2phOx-
GFP with and without FkpA in XL-1 Blue and T2phOx-GFP without FkpA in BL21. (A) Detection with anti-His6 and anti-
mouse IgG-HRP Ab from sheep.  (B) Detection with rabbit anti-human lambda L-chain of the scFv anti-phOx. 
 
Figure 23: SDS-PAGE and Western blot of normalized periplasmic fractions from expression of PphOx-GFP and T2phOx-
GFP with and without FkpA in XL-1 Blue and T2phOx-GFP without FkpA in BL21. Detection of FkpA with anti-Flag M2-
HRP. 
 
Effect on relative fluorescence in cells 
The effect of temperature on the fluorescent properties was further investigated by measuring 
the relative fluorescence of cells expressed at 16°C and 30°C. Effect of temperature on 
fluorescence of cells expressed without induction is shown in Figure 24 and with induction is 
shown in Figure 25.  
 
Figure 24 shows that without induction, reducing the temperature had little or no effect on the 
relative fluorescence, with the exception of phOx-GFP with TorA2 leader which shows that 
expression at 30°C results in four-fold increase in relative fluorescence.  
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Figure 25 shows that phOx-GFP with TorA2 leader without FkpA, and phOx-GFP with both 
leaders with FkpA showed an increase in relative fluorescence when the expression 
temperature was reduced to 16°C. 
 
Effect on fluorescence imaging 
To further examine the fluorescent properties of expression of phOx at different temperatures, 
cells were analyzed in a fluorescence microscopy. The images in Table 10and Table 11, 
visualizes the differences measured by relative fluorescence.  
 
 
Figure 24: Effect of temperature on relative fluorescence in cells without induction. 
 
Figure 25: Effect of temperature on relative fluorescence in cells with induction. 
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Table 10: Fluorescence microscopy of cells expressed at 30°C. 
Without IPTG 
Fase contrast                       FITC filter 
With IPTG 
Fase contrast                            FITC filter 
PphOx-GFP 
T2phOx-GFP 
PphOx-GFPFN 
T2phOx-GFPFN 
T2phOx-GFP (BL21) 
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XL1-Blue 
BL21 
 
Table 11: Fluorescence microscopy of cells expressed at 16°C. 
Without IPTG 
Fase contrast                         FITC filter 
With IPTG 
Fase contrast                          FITC filter 
PphOx-GFP 
T2phOx-GFP 
PphOx-GFPFN 
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T2phOx-GFPFN 
T2phOx-GFP (BL21) 
XL1-Blue 
BL21 
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5 Discussion 
 
Development of novel protein based diagnostics and therapeutics rely heavily on molecular 
evolution of polypeptides with desired properties. After generation of molecular libraries, 
selection and screening of candidate clones are performed. It is crucial to screen a large 
number of clones to identify those with desired properties. However, large scale screening is 
both expensive and time-consuming, even with access to semi-automated methods. Hence, 
screening becomes the bottleneck in selecting candidate clones.  
 
There is a correlation between the solubility of an N-terminal fusion partner to GFP and 
fluorescence in the expressing host cell, namely E. coli (Waldo, Standish et al. 1999). 
Therefore, a feasible solution to generate a screening platform would be to genetically fuse 
GFP to the candidate polypeptide and take advantage of the fluorescent properties of GFP in 
screening. A class of molecules with great therapeutic potential is the soluble TCRs (Molloy, 
Sewell et al. 2005; Varela-Rohena, Molloy et al. 2008) and molecular evolution of soluble 
TCRs is expected to release this potential. Therefore, the TCR clone 4B2A1 from the murine 
MOPC315 myeloma model (Bogen, Malissen et al. 1986; Bogen, Ruffini et al. 2006) has 
been chosen as a fusion partner to GFP in this study. This TCR has been used in phage 
display (Loset, Lunde et al. 2007) and expressed in soluble form (Gunnarsen, Lunde et al. 
submitted). However, substantial manipulation of the expression conditions were required to 
allow functional expression in both cases, due to host cell toxicity and a tendency to 
aggregate, which is generally seen with TCRs. 
  
Previous studies have shown expression of scFv-GFP fusions, but with very low functional 
yields. This appears to be the case whether expressed cytosolic (Schwalbach, Sibler et al. 
2000; Oelschlaeger, Srikant-Iyer et al. 2002; Lu, Gong et al. 2005) or periplasmic, directed by 
a pelB leader sequence (Griep, van Twisk et al. 1999; Casey, Coley et al. 2000). Putative 
explanations for the low yields are that a scFv requires the oxidizing environment to fold 
(DeLisa, Tullman et al. 2003) or that premature folding of the GFP prior to translocation 
decreases the transport efficiency to the periplasm when using a leader sequence that requires 
post translational linear transport. Based on the structural resemblance between the scTCR 
and scFv formats as they both depend on the Ig fold topology (Halaby, Poupon et al. 1999), it 
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is reasonable to expect similar challenges for scTCR-GFP fusions. In addition, functional 
expression of the scTCR with a pelB leader has been found to depend on ectopic folding 
assistance e. g. over-expression of FkpA to obtain soluble periplasmic protein (Wulfing and 
Pluckthun 1994; Maynard, Adams et al. 2005; Gunnarsen, Lunde et al. submitted).   
 
The DsbA signal sequence targets polypeptides to the periplasm through co-translational 
SRP-dependent secretory pathway and thereby prevents polypeptides from folding in the 
cytoplasm (Schierle, Berkmen et al. 2003). The TorA signal sequence targets proteins to the 
Tat-translocator for transport of folded or partially folded domains to the periplasm (Berks, 
Palmer et al. 2005). Premature folding of GFP in the cytoplasm should not impede 
translocation by the DsbA or TorA leader peptides. Thus, a putative solution for creating a 
stringent expression system of scTCR-GFP fusions would be to provide transport to the 
periplasm by the DsbA or TorA signal sequences. An expression system that allows 
periplasmic expression of protein-of-interest-GFP fusions and that also show correlation 
between the functional periplasmic yield and fluorescence has great potential as a screening 
platform. E. g. screening of the scTCR entity could be used to identify clones with improved 
solubility characteristics from a mutated candidate library merely by measuring cell 
fluorescence. Therefore, this study investigates the possibilities of scTCR-GFP expression by 
testing a panel of leaders for increased soluble periplasmic yield and fluorescence. 
 
5.1 Effect of leader peptide 
The expression profiles of the scTCR and scFv entities with pelB leader was investigated by 
expression in XL-1 Blue. We examined if the two scFvs and the scTCR kept their expression 
profiles when genetically fused to GFP and investigated if the scTCR-GFP expression could 
yield periplasmic fusion protein  by utilizing three different leader peptides. All the three 
signal sequences have previously been successfully used for expression of recombinant 
protein in the periplasm (DeLisa, Samuelson et al. 2002; Thie, Schirrmann et al. 2008). 
 
scTCR-GFP 
Most striking was the difference in total and cytosolic expression level between the scTCR-
GFP constructs. The DsbA leader constructs yielded extremely low protein levels compared 
to the pelB leader. In contrast, the TorA leader constructs gave high yields of cytosolic 
70 
 
protein. The only differences between these constructs are the leader sequences. Hence, the 
promoter should give similar transcription levels and the Shine-Dalgarno sequence should 
result in similar translation initiation. Therefore, it is reasonable to assume that the variations 
in total and cytosolic expression levels were caused by differences in the translocation 
pathways and how they affect folding and stability of the polypeptide.  
 
A possible explanation for the extremely low total protein levels from the DsbA leader 
constructs could lie within the nature of the leader sequence: SRP-dependent co-translational 
transport through the Sec-pathway (Schierle, Berkmen et al. 2003). As the ribosome complex 
associates with the translocation units the polypeptide is directed to elongate through the 
transmembrane channel during translation, a failure to translocate could altogether interrupt 
the translation process and result in a degradation-prone polypeptide. Therefore, if the 
predicted transition between the leader and the fusion protein is not fully functional, the 
polypeptide would fail to translocate and thereby prevent translation of the polypeptide. Since 
the translation process seems to be coupled to the translocation process, a low cytoplasmic 
yield is therefore reasonable to expect for the DsbA constructs. 
  
The higher yields of TorA leader constructs compared to the pelB leader construct might also 
be explained by the differences in the translocation pathways. Polypeptides with pelB leader 
are bound by SecB chaperones to maintain an unfolded conformation prior to translocation by 
the Sec-machinery (Driessen 2001). When over-expressing recombinant proteins in need of 
folding chaperones to obtain a correct fold, keeping the polypeptides unfolded might well be a 
limiting step. Specifically, overloading the components that stabilize the unfolded state might 
explain the lower yields of pelB fusions compared to TorA fusions. Vice versa, the higher 
yields of TorA leader constructs compared to the pelB could possibly be explained by the 
nature of the Tat-pathway. Natural substrates of the Tat-pathway are folded or partially folded 
proteins and many of these interact with folding chaperones prior to translocation (Robinson 
and Bolhuis 2004). Folding chaperones interacting with the Tat-pathway might aid the TorA 
fusion proteins to obtain a more stable conformation than the pelB leaders, and hence rescue 
them from degradation or allow a higher accumulation of proteins in the cytosol. 
 
However, none of the leaders yielded scTCR-GFP fusions in the periplasm. Both the pelB and 
DsbA leaders have previously shown to give periplasmic yield of scFv proteins (Thie, 
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Schirrmann et al. 2008), and the TorA leader has shown translocation of a GFP (DeLisa, 
Samuelson et al. 2002) and other proteins (Blaudeck, Kreutzenbeck et al. 2003; DeLisa, 
Tullman et al. 2003). Despite the fact that these leaders have been shown to translocate 
similar domains separately, it is no guarantee for a functional translocation of the proteins as 
fusions.  
 
Despite the lack of periplasmic expression, the TorA constructs showed a high relative 
fluorescence compared to the autofluorescence of empty XL-1 Blue cells. In addition, with 
the scTCR, the TorA versions were the only constructs to show fluorescence in the imaging 
analysis. This indicates that a very small fraction of GFP has reached a fold where it forms a 
functional fluorophore in the cytosol. This is implicated by the fact that PphOx-GFP showed a 
higher fluorescence than the TorA scTCR-GFP, even if the total amount of protein was much 
lower.  
 
As for the fluorescent properties of the cells expressing phOx-GFP, the fluorescence could 
originate from both the cytosol and the periplasm, while the TorA2 scTCR constructs 
exhibited fluorescence despite only cytosolic protein localization. Whether the cleaved 
detected protein in the periplasm exhibited fluorescence was not investigated. Either way, the 
cleaved protein would have uncoupled the fluorescent property from the intended fusion 
partner making it inapplicable for screening purposes.  
 
scFv-GFP 
Initially, the phOx- and NIP-GFP fusions were expressed with pelB leader. We saw that 
recombinant protein was detected in the same fractions as for scFv. However, the fusion 
proteins were not detected as full length proteins, but as cleaved or degraded protein at 
approximately half the size of the fusions. Subsequent expression of phOx-GFP with TorA2 
leader showed the same periplasmic detection of cleaved protein as with the pelB leader, only 
with a higher expression level. 
 
The scFv and GFP entities are of approximately the same size. Since the detection was 
performed with anti-GFP and anti-His6, the immediate assumption was that the detected 
cleavage products of both scFvs were the C-terminal GFP domain. A reasonable explanation 
is that cleavage occurs after translocation, otherwise the domain would not be able to localize 
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to the periplasm. Cleavage during translocation is not equally likely since it occurs with both 
pelB and TorA leaders.  
 
DegP is considered to be the primary housekeeping protease of the periplasm (Baneyx and 
Mujacic 2004). A study of DegP showed that substrates were cleaved at discrete valine/Xaa 
or isoleucine/Xaa sites, Xaa being any aa (Kolmar, Waller et al. 1996).  The study further 
showed that a chimeric protein known to be an in vivo substrate of DegP, was only degraded 
in vitro after reduction of its intramolecular disulfide bond. Hence, Kolmar et al. postulated 
that since the nonpolar valine and isoleucine is typically buried in the hydrophobic core of 
proteins, the main substrates of DegP are transiently denatured proteins, unfolded proteins or 
newly secreted proteins prior to folding and disulphide bond formation. In context of this 
study, one can therefore speculate whether the scFv entity is degraded by DegP prior to 
disulfide bond formation, as a result of an inability to form the disulfide bond or if a valine in 
the proximity of the linker region is part of an unstructured stretch in the folded fusion protein 
making it available for proteolysis. In addition, many proteases, including DegP, are 
upregulated as part of stress responses, e. g. over-expression of heterolog protein  (Baneyx 
and Mujacic 2004).  
 
5.2  Over-expression of chaperones 
 GroEL-GroES 
Over-expression of the cytosolic folding chaperones GroEL-GroES may aid formation of a 
TorA transport-competent fold. In addition, it is possible that the phOx-GFP construct would 
obtain a conformation more resistant to cleavage. Therefore, scTCR-GFP and phOx-GFP 
constructs with pelB, TorA1 and TorA2 leaders were expressed in XL-1 Blue with the over-
expression of GroEL-GroES. 
 
Over-expression of GroEL-GroES did however not result in any periplasmic protein for the 
scTCR-GFP constructs. A possible explanation is that the scTCR entity is not able to reach a 
transport-competent fold in the reducing environment of the cytoplasm, even with GroEL-
GroES folding assistance. GroEL-GroES has broad substrate specificity and has been shown 
to provide folding assistance to proteins as large as 60 kDa (Ellis 2001). It is therefore 
unlikely that the scTCR entity is a poor substrate for folding assistance.  
73 
 
 
The phOx-GFP construct with TorA leader was detected in the periplasm as cleaved fusion 
protein. This indicates that GroEL-GroES did not aid the fusion protein to obtain a fold that 
prevents the previously observed proteolysis. Since cleavage probably occurs in the 
unfolded/unstructured linker region, it is reasonable that GroEL-GroES did not impact the 
cleavage. However, the over-expression of GroEL-GroES abolished the previously detected 
cleaved protein in the periplasm from expression of phOx-GFP with pelB leader. This result 
supports that cytosolic folding assistance impedes the translocation of pelB leader constructs. 
 
FkpA 
To further investigate if over-expression of chaperones could result in full length periplasmic 
yields scTCR-GFP or phOx-GFP constructs, the periplasmic chaperone FkpA was chosen. 
Over-expression of this chaperone has previously been shown to give soluble periplasmic 
protein of scTCR (Gunnarsen, Lunde et al. submitted). Therefore, FkpA was over-expressed 
together with scTCR-GFP and phOx-GFP fusions with pelB and TorA2 leader in XL-1 Blue. 
 
The over-expression of FkpA did not change the total expression level of scTCR-GFP fusions 
with pelB and TorA2 leader and there was still no detection of proteins in the periplasm. 
Furthermore, the relative fluorescence measured in cell samples and fluorescent imaging 
properties were not affected by the FkpA over-expression. Since the fusion proteins were not 
detected in the periplasm, they are not expected to become substrates of the periplasmic 
FkpA. However, it is possible that translocation occur, but that the intrinsic properties of the 
polypeptide make it unable to obtain a stable fold despite the oxidizing environment and 
folding assistance. Hence, the over-expression of FkpA did not change the expression profile 
or fluorescence properties of the scTCR-GFP fusions.   
 
The over-expression of FkpA did not alter the total expression level of phOx-GFP with pelB 
leader. However, the total expression level of phOx-GFP with TorA2 leader was reduced. The 
periplasmic expression level of cleaved fusion protein was reduced with the over-expression 
of FkpA independent of leader. If FkpA and the translocation pathways utilized by the leader 
sequences share key componenets, the over-expression of FkpA could result in this reduced 
transport level. 
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It is tempting to suggest that the detection of translocated protein is just as dependent on the 
protein obtaining a stable fold after translocation as it is of the translocation itself. Hence, the 
ability of the scTCR-GFP fusions to obtain a stable fold in the periplasm is a limiting step in 
addition to the translocation process itself.  
 
The further analysis of the fluorescent properties showed that the pelB phOx-GFP construct 
obtained a higher relative fluorescence with FkpA. Since the periplasmic expression level 
decreased simultaneously, it is possible that the fluorescence originates from the cytosol or 
that a larger fraction of the periplasmic protein exhibits fluorescence due to the periplasmic 
folding assistance of FkpA. In contrast, the TorA2 construct experienced a dramatic reduction 
in relative fluorescence when FkpA was co-expressed. The fluorescence images of the TorA2 
construct with and without FkpA reveal that the drop in fluorescence can be cause by the fact 
that only some cells show fluorescence when FkpA is over-expressed, while almost all the 
cells show fluorescence without FkpA. The decrease in fluorescence of the TorA construct 
also correlates with the abovementioned decreased expression level.  
 
5.3 Expression hosts 
To further investigate the possibilities of obtaining full length fusion proteins in the 
periplasm, different expression host strains were tested. 
 
Rosetta Blue (DE3) pLysS  
The Rosetta Blue strain contains extra tRNA genes for expression of proteins with codons 
rarly used in E. coli that have been shown to increase expression of heterologous proteins 
(Bukhtiyarova, Northrop et al. 2004). The scTCR-GFP and phOx-GFP fusions with pelB and 
TorA2 leader, with and without FkpA, were expressed in Rosetta Blue and XL-1 Blue for 
comparison.  
 
There was only a minor effect of Rosetta Blue on total and periplasmic expression level of 
phOx-GFP fusions and in all situations the periplasmic yield was cleaved protein. There 
seemed to be one exception, the phOx-GFP with TorA2 leader and over-expression of FkpA. 
Here a great increase in the yield of cleaved protein in the periplasm was observed when 
75 
 
expressed in Rosetta Blue. However, the validation of the FkpA expression showed that this 
particular construct only gave a minor detectable yield of FkpA in the periplasm.  
 
When over-expressing proteins and tRNAs it is important to consider the stress inflicted on 
the cell in context of the stability of the protein in interest. The non-fused scTCR is not 
expressed in the periplasm when using the same stringent expression system that expresses 
high soluble periplasmic yields of phOx. Therefore, it is reasonable to expect the scTCR-GFP 
fusions to be less stable than the phOx-GFP fusions, and therefore more sensitive to over-
expression of other proteins and tRNAs. Hence, the scTCR-GFP shows greater variation in 
the effect of Rosetta Blue as an expression host than phOx-GFP.  
 
BL21 
To investigate the possibility of obtaining full length periplasmic fusion protein, phOx-GFP 
with TorA2 leader was expressed in the E. coli strain BL21. This strain is deficient in the 
cytosolic lon and periplasmic ompT proteases (Terpe 2006), possible contributors to the 
observed cleavage. 
 
The phOx-GFP with TorA2 showed a decreased total expression level and relative 
fluorescence when expressed in BL21 compared to XL-1 Blue. In addition, expression in 
BL21 did not result in any detectable periplasmic yield, not even the cleaved fusion proteins 
previously observed in XL-1 Blue. Hence, these results indicate that the cells need the quality 
control provided by the lon and ompT proteases to maintain a high expression level and to 
gain periplasmic yield of the fusion protein.  
 
5.4 Expression conditions 
To further investigate the possibility of obtaining full length periplasmic fusion proteins, the 
effects of induction and expression temperature were investigated.  
 
5.4.1 Induction 
It has previously been shown that expression without IPTG induction improved the 
periplasmic yield of the soluble scTCR (Gunnarsen, Lunde et al. submitted). This effect is 
presumably due to low level transcription of heterologous component only, which alleviates 
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the metabolic load conferred upon the host during heterologous protein over-expression. 
Therefore, phOx-GFP with pelB and TorA2 leader, with and without FkpA, were expressed in 
XL-1 Blue with and without induction. 
 
Induction versus no induction did not significantly affect the total expression level of any of 
the four constructs. Transport of fusion proteins to the periplasm seemed to be more affected 
by induction of protein expression. The pelB constructs seemed dependent on induction to be 
transported, while the TorA constructs were either not affected or negatively affected by 
induction. When the protein in question is aggregation prone or unstable, an increased 
transcription and translation level triggered by induction might cause stress responses in the 
cell resulting in a reduced functional yield. Hence, the different effects of induction probably 
reflect the variation of an optimal expression level of the phOx-GFP construct targeted to 
different transport pathways and with or without the over-expression of FkpA. Irrespectively 
of induction, no full length fusion protein was detected in the periplasm. 
 
Furthermore, induction of pelB constructs gave increased relative fluorescence of the cells. 
This could indicate that the increased fluorescence is correlated to the periplasmic 
localization, even though it represents cleaved protein. In contrast, the TorA leader constructs 
showed a decrease in relative fluorescence when induced. The decreased fluorescence and 
periplasmic yield of the TorA construct with FkpA upon induction might be caused by the 
simultaneous over-expression of two proteins, enhanced by induction, and possible 
overloading of shared key components in the transport pathways. 
 
5.4.2 Temperature 
A previous study has reported periplasmic yield of full length scFv-GFP when performing the 
expression at 16°C for 48 hours (Griep, van Twisk et al. 1999). Therefore, the constructs 
expressed with and without induction was also expressed at both standard expression 
conditions (30°C ON) and 16°C for 48 hours.  
 
Without induction the total expression level of all constructs gave a dramatically reduced 
yield when the expression temperature was lowered to 16°C. However, when induced,  the 
pelB constructs gave reduced yields and while the TorA constructs obtained increased yields 
at 16°C. Furthermore, the periplasmic yield did not seem to be affected by the expression 
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temperature and did not result in full length fusion protein. Expression at reduced 
temperatures is thought to be beneficial for aggregation prone proteins by making them fold 
slower. However, the overall functions of the cell are also affected by the reduced 
temperature. Therefore, a putative explanation is that these combined effects result in the 
opposing effects observed when lowering the expression temperature. 
 
In summary, lowering of the expression temperature and expressing without induction did not 
resulted in full length periplasmic fusion protein. However, the cleaved fusion protein that 
was detected is the C-terminal GFP entity as it is recognized by anti-GFP and anti-His6.  
 
5.5 Additional detections 
To examine if the scFv entity was present in the periplasm, the periplasmic fractions were 
detected with anti-human lambda L-chain. The detection showed bands at ~30 kDa, consistent 
with the scFv entity, when phOx-GFP was expressed with a pelB leader. Surprisingly, no 
bands were visible when expressed with the TorA leader.  
 
A pervious study showed that Tat-transport of a scFv was dependent on an oxidizing 
cytoplasm (DeLisa, Tullman et al. 2003), presumably by allowing the scFv to reach a 
transport competent fold by facilitating disulfide bond formation. In addition, another study 
showed that an in vivo substrate of the periplasmic protease DegP was degraded in vitro only 
after reduction of its intramolecular disulfide bond (Kolmar, Waller et al. 1996), presumably 
due to exposure of cleavage sites when not stably folded with disulfide bonds.  
 
It is reasonable to assume that transport to the periplasm of the scFv with TorA leader could 
be rescued by the genetic fusion to GFP. Hence, a putative explanation is that the scFv 
domain was degraded by DegP in the periplasm due to an unstable fold while the GFP domain 
is stably folded and degradation resistant. In contrast, when the fusion protein is expressed 
with pelB leader, the protein is transported as a linear polypeptide to the oxidizing 
environment of the periplasm. Hence, the polypeptide starts its folding in a disulfide bond 
promoting environment and both the scFv and GFP obtains a stable conformation persisting 
after cleavage.  
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Still, no full length fusion protein had been detected in the periplasm. To examine if a only 
minute amount of full length protein was present, a western blot detected with anti-His6 was 
developed with very sensitive femto-substrate and over-exposed. Only one of the constructs 
showed a vague band at ~60 kDa, namely phOx-GFP with pelB leader and FkpA expressed at 
30°C without induction. Interestingly, cells expressing this construct with the given 
conditions barely showed any fluorescence in the microscopic analysis. The relative 
fluorescence was higher than the autofluorescence of empty cells though, but much lower 
than what was obtained with other constructs and expression conditions.  
 
5.6 Concluding remarks 
This study has showed that the TorA leader provides a higher total expression level of 
scTCR-GFP than the DsbA and pelB leader. Moreover, only the TorA construct-containing 
host cells exhibited a fluorescent phenotype. However, none of the leaders provided 
periplasmic yield of the fusion protein. Neither over-expression of GroEL-GroES nor FkpA, 
nor expression in Rosetta Blue resulted in periplasmic yield of any full length fusion protein.  
 
We saw that phOx-GFP fusions are translocated to the periplasm with both pelB and TorA 
leaders. However, they are detected as half-sized proteins, probably cleaved in the linker 
region connecting the two moieties. Over-expression of GroEL-GroES or FkpA, expression in 
Rosetta Blue or BL21, expression at 16°C or without induction did not yield full length fusion 
protein in the periplasm.  
 
The only periplasmic full length fusion proteins detected was phOx-GFP when expressed with 
pelB leader at 30°C with over-expression of FkpA without induction. However, the minute 
yield excludes it for use in any downstream application.  
 
In conclusion, the study showed that the expression profiles of the scFvs were not preserved 
when expressed as fusions to GFP and that the scTCR-GFP fusions were not translocated to 
periplasm. Hence, further optimalization of expression procedure or construct design is 
needed.  
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6 Future perspectives 
 
In order to establish a screening platform based on the constructs described in this study, the 
expression and/or construct design need to be further improved. 
 
6.1 Expression host 
A whole panel of host strains with different properties could be benchmarked against each 
other, as shown in the table below. In addition to the different strains, each construct can be 
expressed with and without the over-expression of FkpA. The most “pimped” system would 
be expression in the Origami B strain pretransformed with the pGro7 with over-expression of 
FkpA. This would facilitate disulfide bond formation in the cytoplasm together with cytosolic 
and periplasmic folding assistance in a cell deficient of lon and ompT proteases to increase the 
protein stability.  
 
Genotype/  
plasmid 
 
Phenotype 
lon/ompT mut  
 
Less degradation 
 increased 
stability 
trxB/gor mut 
 
Oxydizing cytosol 
disulfide bond 
formation 
pRARE 
 
Express rare 
tRNAs 
pGro7 
 
GroEL/ES  
cytosolic folding 
assistance 
XL-1 Blue - - - - 
XL-1 Blue + 
pGro7 
- - - + 
BL21 + - - - 
Rosetta Blue 
(DE3)pLysS 
- - + - 
Origami B (DE3) 
 
+ + - - 
Rosetta-gami B 
(DE3) pLysS 
+ + + - 
Origami B + 
pGro7 
+ + - + 
 
It is possible that periplasmic expression of scTCR-GFP would result in the same cleavage as 
observed with phOx-GFP. This is based on the sequence similarity of the phOx-GFP and 
scTCR-GFP linker regions and the presence of both valine and isoleucine which are part of 
DegP substrate cleavage sites (Kolmar, Waller et al. 1996). 
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             scFv  -   Linker  -  GFP 
phOx-GFP:  V  L  G -  A  A  A  - G  S  K G 
scTCR-GFP: L  V  I -  A  A  A  - G  S  K G 
 
If cleaved periplasmic scTCR-GFP is expressed, a putative solution for both the scTCR and 
phOx fusions would be to express in a DegP-deficient strain if available. 
 
6.2 Construct design 
It would be desirable to change residues in the vicinity of the linker region of the scFv and 
scTCR constructs to alleviate proteolysis. 
 
6.3 The SsrA peptide 
To eliminate background fluorescence of protein in the cytosol, an SsrA peptide could be 
genetically fused to the C-terminal end of the fusion protein that would lead to degradation of 
cytosolic protein (DeLisa, Samuelson et al. 2002). Hence, all fluorescence from the cell 
would originate from periplasmic protein rescued from cytosolic degradation by translocation. 
This is undoubtedly a desired quality in the expression system to create a strong correlation 
between folded periplasmically expressed protein and fluorescence. 
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